10-Q 1 lpth-10q_033117.htm QUARTERLY REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2017

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ____________

Commission file number 000-27548

LIGHTPATH TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

DELAWARE |  | 86-0708398
(State or other jurisdiction of |  | (I.R.S. Employer
incorporation or organization) |  | Identification No.)

http://www.lightpath.com

2603 Challenger Tech Ct. Suite 100

Orlando, Florida 32826

(Address of principal executive offices)

(ZIP Code)

(407) 382-4003

(Registrant’s telephone number, including area code)

N/A

(Former name, former address, and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ☒ NO ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit and post such files).

YES ☒ NO ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ☐ | Accelerated filer ☐ | Non-accelerated filer ☐ | Smaller reporting company ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO ☒

APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

24,115,733 shares of common stock, Class A, $.01 par value, outstanding as of May 1, 2017.

LIGHTPATH TECHNOLOGIES, INC.

Form 10-Q

Index
|  | Page
Item |  |
Part I | Financial Information |
Item 1 | Financial Statements |
| Unaudited Consolidated Balance Sheets | 3
| Unaudited Consolidated Statements of Comprehensive Income | 4
| Unaudited Consolidated Statement of Stockholders’ Equity | 5
| Unaudited Consolidated Statements of Cash Flows | 6
| Notes to Unaudited Consolidated Financial Statements | 7
Item 2 | Management’s Discussion and Analysis of Financial Condition and Results of Operations Overview | 25
| Results of Operations | 26
| Liquidity and Capital Resources | 29
| Non-GAAP Financial Measures | 35
| Off Balance Sheet Arrangements | 37
| Critical Accounting Policies and Estimates | 37
Item 4 | Controls and Procedures | 37
Part II | Other Information |
Item 1 | Legal Proceedings | 38
Item 2 | Unregistered Sales of Equity Securities and Use of Proceeds | 38
Item 3 | Defaults Upon Senior Securities | 38
Item 4 | Mine Safety Disclosures | 38
Item 5 | Other information | 38
Item 6 | Exhibits | 39
Signatures | 41

| 2 |

Item 1. Financial Statements

LIGHTPATH TECHNOLOGIES, INC.

Consolidated Balance Sheets

(unaudited)

|  | March 31, 2017 |  |  | June 30, 2016 |
Assets |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 6,831,521 |  |  | $ | 2,908,024 |
Trade accounts receivable, net of allowance of $7,313 and $4,598 |  |  | 5,740,041 |  |  |  | 3,545,871 |
Inventories, net |  |  | 5,083,350 |  |  |  | 3,836,809 |
Other receivables |  |  | 77,336 |  |  |  | 209,172 |
Prepaid expenses and other assets |  |  | 615,353 |  |  |  | 652,308 |
Total current assets |  |  | 18,347,601 |  |  |  | 11,152,184 |
Property and equipment, net |  |  | 9,763,042 |  |  |  | 4,370,045 |
Intangible assets, net |  |  | 10,930,191 |  |  |  | — |
Goodwill |  |  | 513,940 |  |  |  | — |
Other assets |  |  | 158,414 |  |  |  | 66,964 |
Total assets |  | $ | 39,713,188 |  |  | $ | 15,589,193 |
Liabilities and Stockholders’ Equity |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |
Accounts payable |  | $ | 1,597,144 |  |  | $ | 1,361,914 |
Accrued liabilities |  |  | 1,215,080 |  |  |  | 328,144 |
Accrued payroll and benefits |  |  | 1,419,357 |  |  |  | 1,356,255 |
Loans payable, current portion |  |  | 833,750 |  |  |  | — |
Capital lease obligation, current portion |  |  | 239,981 |  |  |  | 166,454 |
Total current liabilities |  |  | 5,305,312 |  |  |  | 3,212,767 |
Capital lease obligation, less current portion |  |  | 193,518 |  |  |  | 178,919 |
Deferred rent |  |  | 481,492 |  |  |  | 548,202 |
Warrant liability |  |  | 665,406 |  |  |  | 717,393 |
Loans payable, less current portion |  |  | 10,166,505 |  |  |  | — |
Total liabilities |  |  | 16,812,233 |  |  |  | 4,657,281 |
Stockholders’ equity: |  |  |  |  |  |  |  |
Preferred stock: Series D, $.01 par value, voting; 100,000 shares authorized; none issued and outstanding |  |  | — |  |  |  | — |
Common stock: Class A, $.01 par value, voting; 34,500,000 shares authorized; 24,115,733 and 15,590,945 shares issued and outstanding |  |  | 241,157 |  |  |  | 155,909 |
Additional paid-in capital |  |  | 225,092,607 |  |  |  | 214,661,617 |
Accumulated other comprehensive income |  |  | 239,926 |  |  |  | 126,108 |
Accumulated deficit |  |  | (202,672,735 | ) |  |  | (204,011,722 | )
Total stockholders’ equity |  |  | 22,900,955 |  |  |  | 10,931,912 |
Total liabilities and stockholders’ equity |  | $ | 39,713,188 |  |  | $ | 15,589,193 |

The accompanying notes are an integral part of these unaudited consolidated statements.

| 3 |

LIGHTPATH TECHNOLOGIES, INC.

Consolidated Statements of Comprehensive Income

(unaudited)

|  | Three months ended March 31, |  |  | Nine months ended March 31, |
|  | 2017 |  |  | 2016 |  |  | 2017 |  |  | 2016 |
Revenue, net |  | $ | 8,490,042 |  |  | $ | 4,111,973 |  |  | $ | 19,360,109 |  |  | $ | 12,538,634 |
Cost of sales |  |  | 4,267,318 |  |  |  | 1,887,146 |  |  |  | 9,007,180 |  |  |  | 5,702,239 |
Gross margin |  |  | 4,222,724 |  |  |  | 2,224,827 |  |  |  | 10,352,929 |  |  |  | 6,836,395 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Selling, general and administrative |  |  | 2,329,762 |  |  |  | 1,812,205 |  |  |  | 6,190,705 |  |  |  | 4,822,118 |
New product development |  |  | 308,394 |  |  |  | 164,990 |  |  |  | 853,939 |  |  |  | 481,403 |
Amortization of intangibles |  |  | 304,809 |  |  |  | — |  |  |  | 304,809 |  |  |  | — |
Loss on disposal of property and equipment |  |  | — |  |  |  | 34,189 |  |  |  | — |  |  |  | 46,065 |
Total costs and expenses |  |  | 2,942,965 |  |  |  | 2,011,384 |  |  |  | 7,349,453 |  |  |  | 5,349,586 |
Operating income |  |  | 1,279,759 |  |  |  | 213,443 |  |  |  | 3,003,476 |  |  |  | 1,486,809 |
Other income (expense): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest expense |  |  | (154,639 | ) |  |  | (8,287 | ) |  |  | (167,832 | ) |  |  | (30,100 | )
Interest expense - debt costs |  |  | (38,338 | ) |  |  | — |  |  |  | (38,338 | ) |  |  | — |
Change in fair value of warrant liability |  |  | (748,169 | ) |  |  | 661,854 |  |  |  | (457,784 | ) |  |  | (25,211 | )
Other income (expense), net |  |  | 27,985 |  |  |  | 35,718 |  |  |  | (228,935 | ) |  |  | (217,296 | )
Total other income (expense), net |  |  | (913,161 | ) |  |  | 689,285 |  |  |  | (892,889 | ) |  |  | (272,607 | )
Net income before income taxes |  |  | 366,598 |  |  |  | 902,728 |  |  |  | 2,110,587 |  |  |  | 1,214,202 |
Income taxes |  |  | 265,774 |  |  |  | 126,970 |  |  |  | 771,600 |  |  |  | 131,054 |
Net income |  | $ | 100,824 |  |  | $ | 775,758 |  |  | $ | 1,338,987 |  |  | $ | 1,083,148 |
Foreign currency translation adjustment |  |  | 38,636 |  |  |  | 26,258 |  |  |  | 113,818 |  |  |  | 47,181 |
Comprehensive income |  | $ | 139,460 |  |  | $ | 802,016 |  |  | $ | 1,452,805 |  |  | $ | 1,130,329 |
Earnings per common share (basic) |  | $ | 0.00 |  |  | $ | 0.05 |  |  | $ | 0.07 |  |  | $ | 0.07 |
Number of shares used in per share calculation (basic) |  |  | 23,818,136 |  |  |  | 15,530,574 |  |  |  | 18,621,072 |  |  |  | 15,339,337 |
Earnings per common share (diluted) |  | $ | 0.00 |  |  | $ | 0.04 |  |  | $ | 0.07 |  |  | $ | 0.06 |
Number of shares used in per share calculation (diluted) |  |  | 25,628,703 |  |  |  | 17,404,152 |  |  |  | 20,145,976 |  |  |  | 16,843,880 |

The accompanying notes are an integral part of these unaudited consolidated statements.

| 4 |

LIGHTPATH TECHNOLOGIES, INC.
Consolidated Statement of Stockholders’ Equity
Nine months ended March 31, 2017
(unaudited)

|  |  |  |  |  |  |  |  |  |  | Accumulated |  |  |  |  |  |  |
|  | Class A |  |  |  |  |  | Additional |  |  | Other |  |  |  |  |  | Total |
|  | Common Stock |  |  |  |  |  | Paid-in |  |  | Comphrehensive |  |  | Accumulated |  |  | Stockholders’ |
|  | Shares |  |  | Amount |  |  | Capital |  |  | Income |  |  | Deficit |  |  | Equity |
Balances at June 30, 2016 |  |  | 15,590,945 |  |  | $ | 155,909 |  |  | $ | 214,661,617 |  |  | $ | 126,108 |  |  | $ | (204,011,722 | ) |  | $ | 10,931,912 |
Issuance of common stock for: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of warrants |  |  | 478,897 |  |  |  | 4,789 |  |  |  | 579,890 |  |  |  | — |  |  |  | — |  |  |  | 584,679 |
Employee Stock Purchase Plan |  |  | 12,106 |  |  |  | 121 |  |  |  | 19,511 |  |  |  | — |  |  |  | — |  |  |  | 19,632 |
Exercise of RSU or options |  |  | 33,785 |  |  |  | 338 |  |  |  | (338 | ) |  |  | — |  |  |  | — |  |  |  | — |
Public equity placement, net of costs |  |  | 8,000,000 |  |  |  | 80,000 |  |  |  | 8,650,209 |  |  |  | — |  |  |  | — |  |  |  | 8,730,209 |
Reclassification of warrant liability upon exercise |  |  | — |  |  |  | — |  |  |  | 509,771 |  |  |  | — |  |  |  | — |  |  |  | 509,771 |
Stock based compensation on stock options & RSU |  |  | — |  |  |  | — |  |  |  | 671,947 |  |  |  | — |  |  |  | — |  |  |  | 671,947 |
Foreign currency translation adjustment |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 113,818 |  |  |  | — |  |  |  | 113,818 |
Net income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,338,987 |  |  |  | 1,338,987 |
Balances at March 31, 2017 |  |  | 24,115,733 |  |  | $ | 241,157 |  |  | $ | 225,092,607 |  |  | $ | 239,926 |  |  | $ | (202,672,735 | ) |  | $ | 22,900,955 |

The accompanying notes are an integral part of these unaudited consolidated statements.

| 5 |

LIGHTPATH TECHNOLOGIES, INC.

Consolidated Statements of Cash Flows

(unaudited)

|  | Nine months ended |
|  | March 31, |
|  | 2017 |  |  | 2016 |
Cash flows from operating activities |  |  |  |  |  |  |  |
Net income |  | $ | 1,338,987 |  |  | $ | 1,083,148 |
Adjustments to reconcile net income to net cash provided by operating activities: |  |  |  |  |  |  |  |
Depreciation and amortization |  |  | 1,240,232 |  |  |  | 609,029 |
Interest from amortization of debt costs |  |  | 3,861 |  |  |  | — |
Loss on disposal of property and equipment |  |  | — |  |  |  | 46,065 |
Stock based compensation |  |  | 319,182 |  |  |  | 261,615 |
Provision for doubtful accounts receivable |  |  | (29,551 | ) |  |  | (289 | )
Change in fair value of warrant liability |  |  | 457,784 |  |  |  | 25,211 |
Change in fair value of seller’s note |  |  | 34,476 |  |  |  | — |
Deferred rent |  |  | (66,710 | ) |  |  | 43,153 |
Inventory write-offs to reserve |  |  | 47,895 |  |  |  | — |
Deferred tax expense |  |  | (40,000 | ) |  |  | — |
Changes in operating assets and liabilities: |  |  |  |  |  |  |  |
Trade accounts receivables |  |  | (1,032,243 | ) |  |  | (133,884 | )
Other receivables |  |  | 142,919 |  |  |  | 42,947 |
Inventories |  |  | (253,179 | ) |  |  | (657,596 | )
Prepaid expenses and other assets |  |  | 171,753 |  |  |  | (241,450 | )
Accounts payable and accrued liabilities |  |  | 595,624 |  |  |  | 157,877 |
Net cash provided by operating activities |  |  | 2,931,030 |  |  |  | 1,235,826 |
Cash flows from investing activities |  |  |  |  |  |  |  |
Purchase of property and equipment |  |  | (1,412,738 | ) |  |  | (755,800 | )
Proceeds from sale of equipment |  |  | — |  |  |  | 5,916 |
Acquisiton of ISP Optics, net of cash acquired |  |  | (11,777,336 | ) |  |  | — |
Net cash used in investing activities |  |  | (13,190,074 | ) |  |  | (749,884 | )
Cash flows from financing activities |  |  |  |  |  |  |  |
Proceeds from exercise of stock options |  |  | — |  |  |  | 6,430 |
Proceeds from sale of common stock from employee stock purchase plan |  |  | 19,632 |  |  |  | 22,903 |
Loan costs |  |  | (72,224 | ) |  |  | — |
Borrowings on loan payable |  |  | 5,000,000 |  |  |  | — |
Proceeds from issuance of common stock under public equity placement |  |  | 8,730,209 |  |  |  | — |
Proceeds from exercise of warrants, net of costs |  |  | 584,679 |  |  |  | 391,082 |
Net payments on loan payable |  |  | — |  |  |  | (51,585 | )
Payments on capital lease obligations |  |  | (141,874 | ) |  |  | (96,718 | )
Net cash provided by financing activities |  |  | 14,120,422 |  |  |  | 272,112 |
Effect of exchange rate on cash and cash equivalents |  |  | 62,119 |  |  |  | 460,612 |
Change in cash and cash equivalents |  |  | 3,923,497 |  |  |  | 1,218,666 |
Cash and cash equivalents, beginning of period |  |  | 2,908,024 |  |  |  | 1,643,920 |
Cash and cash equivalents, end of period |  | $ | 6,831,521 |  |  | $ | 2,862,586 |
Supplemental disclosure of cash flow information: |  |  |  |  |  |  |  |
Interest paid in cash |  | $ | 91,525 |  |  | $ | 30,101 |
Income taxes paid |  | $ | 344,820 |  |  | $ | 2,056 |
Supplemental disclosure of non-cash investing & financing activities: |  |  |  |  |  |  |  |
Purchase of equipment through capital lease arrangements |  | $ | 230,000 |  |  | $ | — |
Reclassification of warrant liability upon exercise |  | $ | 509,771 |  |  | $ | — |
Derecognition of liability associated with stock option grants |  | $ | 352,765 |  |  | $ | 143,125 |
Seller note issued to acquire ISP Optics, at fair value |  | $ | 6,327,208 |  |  | $ | — |

The accompanying notes are an integral part of these unaudited consolidated statements.

6

Notes to Financial Statements

1. Basis of Presentation

References in this document to “the Company,” “LightPath,” “we,” “us,” or “our” are intended to mean LightPath Technologies, Inc., individually, or as the context requires, collectively with its subsidiaries on a consolidated basis.

The accompanying unaudited consolidated financial statements have been prepared in accordance with the requirements of Article 8 of Regulation S-X promulgated under the Securities Exchange Act of 1934, as amended, and, therefore, do not include all information and footnotes necessary for a fair presentation of financial position, results of operations, and cash flows in conformity with accounting principles generally accepted in the United States of America. These consolidated financial statements should be read in conjunction with our consolidated financial statements and related notes, included in our Annual Report on Form 10-K, as amended, for the fiscal year ended June 30, 2016, filed with the Securities and Exchange Commission (the “SEC”). Unless otherwise stated, references to particular years or quarters refer to our fiscal years ended June 30 and the associated quarters of those fiscal years.

These consolidated financial statements are unaudited, but include all adjustments, including normal recurring adjustments, which, in the opinion of management, are necessary to present fairly our financial position, results of operations and cash flows for the interim periods presented. Results of operations for interim periods are not necessarily indicative of the results that may be expected for the year as a whole.

History:

We were incorporated in Delaware in 1992 as the successor to LightPath Technologies Limited Partnership, a New Mexico limited partnership, formed in 1989, and its predecessor, Integrated Solar Technologies Corporation, a New Mexico corporation, formed in 1985. We completed our initial public offering (“IPO”) during fiscal 1996. On April 14, 2000, we acquired Horizon Photonics, Inc. (“Horizon”). On September 20, 2000, we acquired Geltech, Inc. (“Geltech”). In November 2005, we formed LightPath Optical Instrumentation (Shanghai) Co., Ltd (“LPOI”), a wholly-owned subsidiary located in Jiading, People’s Republic of China. In December 2013, we formed LightPath Optical Instrumentation (Zhenjiang) Co., Ltd (“LPOIZ”), a wholly-owned subsidiary located in Zhenjiang, Jiangsu Province, People’s Republic of China. In December 2016, we acquired ISP Optics Corporation, a New York corporation (“ISP”), and its wholly-owned subsidiary, ISP Optics Latvia, SIA, a limited liability company founded in 1998 under the Laws of the Republic of Latvia (“ISP Latvia”). See Note 3, Acquisition of ISP Optics Corporation, to these consolidated financial statements, for additional information.

We are a manufacturer and integrator of families of precision molded aspheric optics, high-performance fiber-optic collimator, GRADIUM glass lenses and other optical materials used to produce products that manipulate light. We design, develop, manufacture and distribute optical components and assemblies utilizing the latest optical processes and advanced manufacturing technologies. We also engage in research and development for optical solutions for the traditional optics markets and communications markets.

2. Significant Accounting Policies

Consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Cash and cash equivalents consist of cash in the bank and temporary investments with maturities of 90 days or less when purchased.

Allowance for accounts receivable, is calculated by taking 100% of the total of invoices that are over 90 days past due from the due date and 10% of the total of invoices that are over 60 days past due from the due date for U.S. based accounts and 100% of invoices that are over 120 days past due for Chinese and Latvian based accounts. Accounts receivable are customer obligations due under normal trade terms. We perform continuing credit evaluations of our customers’ financial condition. If our actual collection experience changes, revisions to our allowance may be required. After all attempts to collect a receivable have failed, the receivable is written off against the allowance.

Inventories, which consist principally of raw materials, tooling, work-in-process and finished lenses, collimators and assemblies are stated at the lower of cost or market, on a first-in, first-out basis. Inventory costs include materials, labor and manufacturing overhead. Acquisition of goods from our vendors has a purchase burden added to cover customs, shipping and handling costs. Fixed costs related to excess manufacturing capacity have been expensed. We look at the following criteria for parts to consider for the inventory reserve: items that have not been sold in two years or that have not been purchased in two years or of which we have more than a two-year supply. These items as identified are reserved at 100%, as well as reserving 50% for other items deemed to be slow moving within the last twelve months and reserving 25% for items deemed to have low material usage within the last six months. The parts identified are adjusted for recent order and quote activity to determine the final inventory reserve.

7

Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the related assets ranging from one to ten years. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful lives of the related assets using the straight-line method. Construction in process represents the accumulated costs of assets not yet placed in service and primarily relates to manufacturing equipment.

Long-lived assets, such as property, plant, and equipment and purchased intangibles subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to its estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of would be separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell, and are no longer depreciated. The assets and liabilities of a disposed group classified as held for sale would be presented separately in the appropriate asset and liability sections of the balance sheet.

Goodwill and Intangible Assets acquired in a business combination are recognized at fair value using generally accepted valuation methods appropriate for the type of intangible asset and reported separately from goodwill. Purchased intangible assets other than goodwill are amortized over their useful lives unless these lives are determined to be indefinite. Purchased intangible assets are carried at cost, less accumulated amortization. Amortization is computed over the estimated useful lives of the respective assets, generally two to fifteen years. The Company periodically re-assesses the useful lives of its intangible assets when events or circumstances indicate that useful lives have significantly changed from the previous estimate. Definite-lived intangible assets consist primarily of customer relationships, know-how/trade secrets and trademarks. They are generally valued as the present value of estimated cash flows expected to be generated from the asset using a risk-adjusted discount rate. When determining the fair value of our intangible assets, estimates and assumptions about future expected revenue and remaining useful lives are used. Goodwill and intangible assets are tested for impairment on an annual basis and during the period between annual tests in certain circumstances, and written down when impaired. The annual evaluation for impairment of goodwill is based on valuation models that incorporate assumptions and internal projections of expected future cash flows and operating plans.

Deferred rent relates to certain of our operating leases containing predetermined fixed increases of the base rental rate during the lease term being recognized as rental expense on a straight-line basis over the lease term, as well as applicable leasehold improvement incentives provided by the landlord. We have recorded the difference between the amounts charged to operations and amounts payable under the leases as deferred rent in the accompanying consolidated balance sheets.

Income taxes are accounted for under the asset and liability method. Deferred income tax assets and liabilities are computed on the basis of differences between the financial statement and tax basis of assets and liabilities that will result in taxable or deductible amounts in the future based upon enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances have been established to reduce deferred tax assets to the amount expected to be realized.

We have not recognized a liability for uncertain tax positions. A reconciliation of the beginning and ending amount of unrecognized tax benefits or penalties has not been provided since there has been no unrecognized benefit or penalty. If there were an unrecognized tax benefit or penalty, we would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.

8

We file U.S. Federal income tax returns, and various states and foreign jurisdictions. Our open tax years subject to examination by the Internal Revenue Service and the Florida Department of Revenue generally remain open for three years from the date of filing.

Our cash and cash equivalents totaled approximately $6.8 million at March 31, 2017. Of this amount, approximately 52% was held by our foreign subsidiaries in China and Latvia. These foreign funds were generated in China and Latvia as a result of foreign earnings. With respect to the funds generated by our foreign subsidiaries in China, the retained earnings in China must equal at least 150% of the registered capital before any funds can be repatriated. As of March 31, 2017, we have retained earnings in China of approximately $3.3 million and we need to have approximately $11.3 million before repatriation will be allowed.

We currently intend to permanently invest earnings generated from our foreign Chinese and Latvian operations, and, therefore, we have not previously provided for United States taxes on related earnings. However, if in the future we change such intention we would provide for and pay additional United States taxes at that time.

Revenue is recognized from product sales when products are shipped to the customer, provided that the Company has received a valid purchase order, the price is fixed, title has transferred, collection of the associated receivable is reasonably assured, and there are no remaining significant obligations. Product development agreements are generally short term in nature with revenue recognized upon shipment to the customer for products, reports or designs. Invoiced amounts for sales for value-added taxes (“VAT”) are posted to the balance sheet and not included in revenue.

VAT is computed on the gross sales price on all sales of our products sold in the People’s Republic of China and Latvia. The VAT rates range up to 21%, depending on the type of products sold. The VAT may be offset by VAT paid by us on raw materials and other materials included in the cost of producing or acquiring our finished products. We recorded a VAT receivable net of payments, which is included in other receivables in the accompanying financial statements.

New product development costs are expensed as incurred.

Stock-based compensation is measured at grant date, based on the fair value of the award, and is recognized as an expense over the employee’s requisite service period. We estimate the fair value of each restricted stock unit or stock option as of the date of grant using the Black-Scholes-Merton pricing model. Most awards granted under our Amended and Restated Omnibus Incentive Plan (the “Plan”) vest ratably over two to four years and generally have four to ten-year contract lives. The volatility rate is based on historical trends in common stock closing prices and the expected term was determined based primarily on historical experience of previously outstanding awards. The interest rate used is the U.S. Treasury interest rate for constant maturities. The likelihood of meeting targets for option grants that are performance based are evaluated each quarter. If it is determined that meeting the targets is probable then the compensation expense will be amortized over the remaining vesting period.

Management estimates. Management makes estimates and assumptions during the preparation of our consolidated financial statements that affect amounts reported in the financial statements and accompanying notes. Such estimates and assumptions could change in the future as more information becomes available, which in turn could impact the amounts reported and disclosed herein.

9

Fair value of financial instruments. We account for financial instruments in accordance with the Financial Accounting Standard Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 820 – Fair Value Measurements and Disclosures (“ASC 820”), which provides a framework for measuring fair value and expands required disclosure about fair value measurements of assets and liabilities. ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable.

Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing.

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of March 31, 2017.

The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include receivables, accounts payable and accrued liabilities. Fair values were assumed to approximate carrying values for these financial instruments since they are short term in nature and their carrying amounts approximate fair values or they are receivable or payable on demand. The fair value of our capital lease obligations and acquisition term loan in the aggregate principal amount of $5 million (the “Term Loan”) payable to Avidbank Corporate Finance, a division of Avidbank (“Avidbank”) approximates their carrying values based upon current rates available to us. Loans payable also includes a note payable to the Sellers of ISP, in the aggregate principal amount of $6 million (the “Sellers Note”). The carrying value of the note includes a fair value premium based on a risk-adjusted discount rate. See further discussion at Note 12, Loans Payable, to these Consolidated Financial Statements.

We value our warrant liabilities based on open-form option pricing models which, based on the relevant inputs and render the fair value measurement at Level 3. We base our estimates of fair value for warrant liabilities on the amount it would pay a third-party market participant to transfer the liability and incorporates inputs such as equity prices, historical and implied volatilities, dividend rates and prices of convertible securities issued by comparable companies maximizing the use of observable inputs when available. See further discussion at Note 9, Derivative Financial Instruments (Warrant Liability), to these Consolidated Financial Statements.

We do not have any other financial or non-financial instruments that would be characterized as Level 1, Level 2 or Level 3.

Debt issuance costs are recorded as a reduction to the carrying value of the related notes payable, by the same amount, and are amortized ratably over the term of the note.

Derivative financial instruments. We account for derivative instruments in accordance with FASB’s ASC Topic 815 – Derivatives and Hedging (“ASC 815”), which requires additional disclosures about our objectives and strategies for using derivative instruments, how the derivative instruments and related hedged items are accounted for, and how the derivative instruments and related hedging items affect the financial statements.

We do not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. Terms of convertible debt instruments are reviewed to determine whether or not they contain embedded derivative instruments that are required under ASC 815 to be accounted for separately from the host contract, and recorded on the balance sheet at fair value. The fair value of derivative liabilities, if any, is required to be revalued at each reporting date, with corresponding changes in fair value recorded in current period operating results.

Freestanding warrants issued by us in connection with the issuance or sale of debt and equity instruments are considered to be derivative instruments. Pursuant to ASC 815, an evaluation of specifically identified conditions is made to determine whether the fair value of warrants issued is required to be classified as equity or as a derivative liability.

Comprehensive income is defined as the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners. Comprehensive income has two components, net income and other comprehensive income, and is included on the statement of comprehensive income. Our other comprehensive income consists of foreign currency translation adjustments made for financial reporting purposes.

Business segments are required to be reported by us. As we only operate in principally one business segment, no additional reporting is required.

Recent accounting pronouncements. There are new accounting pronouncements issued by the FASB that are not yet effective.

In November 2015, FASB issued Accounting Standards Update (“ASU”) No. 2015-17, “Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes” (“ASU 2015-17”). The standard requires that deferred tax assets and liabilities be classified as noncurrent on the balance sheet rather than being separated into current and noncurrent. ASU 2015-17 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016. Early adoption is permitted and the standard may be applied either retrospectively or on a prospective basis to all deferred tax assets and liabilities. We do not expect the adoption of this guidance to have a material impact on our consolidated financial position, results of operations or cash flows.

10

In March 2016, the FASB issued ASU No. 2016-09, “Compensation — Stock Compensation (Topic 718) — Improvements to Employee Share-Based Payment Accounting” (“ASU 2016-09”). ASU 2016-09 includes provisions to simplify certain aspects related to the accounting for share-based awards and the related financial statement presentation. This ASU includes a requirement that the tax effect related to the settlement of share-based awards be recorded in income tax benefit or expense in the statements of earnings. This change is required to be adopted prospectively in the period of adoption. In addition, the ASU modifies the classification of certain share-based payment activities within the statements of cash flows and these changes are required to be applied retrospectively to all periods presented, or in certain cases prospectively, beginning in the period of adoption. ASU No. 2016-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is permitted. The Company is currently evaluating the impact the adoption of this new standard will have on its financial statements.

In July 2015, the FASB issued No. 2015-11, “Inventory - Simplifying the Measurement of Inventory” (“ASU 2015-11”). ASU 2015-11 provides additional guidance regarding the subsequent measurement of inventory by requiring inventory to be measured at the lower of cost or net realizable value. This guidance is effective for fiscal years and interim periods beginning after December 15, 2016. Early adoption is permitted. We do not expect the adoption of this guidance to have a material impact on our consolidated financial position, results of operations or cash flows.

In May 2014, FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers” (Topic 606), which supersedes the revenue recognition requirements in ASC Topic 605, “Revenue Recognition,” and most industry-specific guidance. This ASU is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments, and assets recognized from costs incurred to obtain or fulfill a contract. The amendments in the ASU must be applied using one of two retrospective methods and were originally set to be effective for annual and interim periods beginning after December 15, 2016. On July 9, 2015, the FASB modified ASU 2014-09 to be effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. As modified, the FASB permits the adoption of the new revenue standard early, but not before the annual periods beginning after December 15, 2017. A public organization would apply the new revenue standard to all interim reporting periods within the year of adoption.

ASU 2014-09 provides that an entity should apply a five-step approach for recognizing revenue, including (1) identifying the contract with a customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price to the performance obligations in the contract; and (5) recognizing revenue when, or as, the entity satisfies a performance obligation. Also, the entity must provide various disclosures concerning the nature, amount and timing of revenue and cash flows arising from contracts with customers. The Company is currently working through the assessment phase of implementing this guidance. We believe that the impact of adopting this guidance will be limited to our product development revenue, which is currently less than 5% of total revenue. The effective date for us will be the first quarter of our fiscal year ending June 30, 2019, using one of two retrospective application methods.

In February 2016, the FASB issued ASU No. 2016-02, “Leases” (“ASU 2016-02”). This guidance requires an entity to recognize lease liabilities and a right-of-use asset for all leases on the balance sheet and to disclose key information about the entity's leasing arrangements. ASU 2016-02 must be adopted using a modified retrospective approach for all leases existing at, or entered into after the date of initial adoption, with an option to elect to use certain transition relief. ASU 2016-02 is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, with earlier adoption permitted. The effective date for us will be the first quarter of our fiscal year ending June 30, 2020. We are evaluating the impact of this standard on our financial position, results of operations, cash flows and related disclosures. The Company’s current operating lease portfolio is primarily comprised of real estate leases. Upon adoption of this standard, we expect our balance sheet to include a right of use asset and liability related to substantially all operating lease arrangements.

3. Acquisition of ISP Optics Corporation

On December 21, 2016 (the “Acquisition Date”), the Company acquired 100% of the issued and outstanding shares of common stock of ISP (the “Acquisition”) pursuant to the Stock Purchase Agreement, dated as of August 3, 2016 (the “Purchase Agreement”). The Company’s consolidated financial statements reflect the financial results of ISP’s operations beginning on the Acquisition Date.

11

Part of our growth strategy is to identify appropriate opportunities that would enhance our profitable growth through acquisition. As we developed our molded infrared capability and learned more about the infrared market, we became aware of larger business opportunities in this market that might be available with a broader range of product capability. We believed acquiring ISP would provide an excellent complementary fit with our business that would meet our requirement of profitable growth in a market space we are investing in, and saw the Acquisition as an opportunity to accelerate our growth, and expand our capabilities and our global reach.

For the purposes of financing the Acquisition, simultaneous with the closing, the Company sold 8,000,000 shares of its Class A common stock, raising net proceeds of approximately $8.7 million. For additional information, please see Note 13 to these Consolidated Financial Statements. The Company also closed a $5 million Term Loan with AvidBank. For additional information, see Note 12, Loans Payable, to these Consolidated Financial Statements.

In lieu of cash paid, the Company financed a portion of the Acquisition through the issuance of the Sellers Note in the aggregate principal amount of $6 million to the Sellers. For additional information, see Note 12, Loans Payable, to these Consolidated Financial Statements.

The Acquisition Date fair value of the consideration transferred totaled approximately $19.1 million, which consisted of the following:

Cash Purchase Price |  | $ | 12,000,000 |
Cash acquired |  |  | 1,243,216 |
Tax payable assumed debt |  |  | (200,477 | )
Fair value of Seller’s Note |  |  | 6,327,208 |
Working capital adjustment |  |  | (315,003 | )
Total purchase price |  | $ | 19,054,944 |
Seller’s Note issued at fair value |  |  | (6,327,208 | )
Premininary working capital adjustment |  |  | (760,822 | )
Adjustment to beginning cash |  |  | (163,878 | )
Adjustment to beginning assumed debt |  |  | (25,700 | )
Cash paid at Acquisition Date |  | $ | 11,777,33 6 |

Subsequently in March 2017, a portion of the working capital adjustment, in the amount of $292,816, was applied to the Sellers Note as a payment, thereby decreasing the outstanding principal amount due under the Sellers Note as reflected in these Consolidated Financial Statements.

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the Acquisition Date. We are in the process of finalizing third-party valuations of certain intangible assets thus, the provisional measurements of intangible assets, goodwill and deferred income tax assets are subject to change. The working capital adjustment was finalized in March 2017.

12

Cash |  | $ | 1,243,216 |
Accounts receivable |  |  | 1,108,980 |
Inventory |  |  | 1,134,628 |
Other Current assets |  |  | 153,450 |
Property and equipment |  |  | 4,546,402 |
Security deposit and other assets |  |  | 45,359 |
Identifiable intangibles |  |  | 11,235,000 |
Total identifiable assets acquired |  | $ | 19,467,035 |
Accounts payable |  |  | (554,050 | )
Accrued expenses and other payables |  |  | (133,974 | )
Other payables |  |  | (238,007 | )
Total liabilities assumed |  | $ | (926,031 | )
Net identifiable assets acquired |  |  | 18,541,004 |
Goodwill |  |  | 513,940 |
Net assets acquired |  | $ | 19,054,944 |

As part of the preliminary valuation analysis, the Company identified intangible assets, including customer relationships, customer backlog, trade secrets, trademarks and non-compete agreements. The customer relationships, customer backlog, trade secrets, trademarks and non-compete agreements were determined to have estimated values of $5,666,000, $376,000, $2,734,000, $2,438,000 and $21,000, respectively, and estimated useful lives of 15, 2, 8, 8, and 3 years, respectively. The estimated fair value of identifiable intangible assets is determined primarily using the “income approach”, which requires a forecast of all future cash flows. This also reflects a $2,532,824 adjustment to increase the basis of the acquired property, plant and equipment to reflect fair value of the assets at the Acquisition Date. The estimated useful lives range from 3 years to 7 years. Depreciation and amortization of intangible assets and property, plant and equipment is calculated on a straight-line basis. This also reflects a $153,132 adjustment to increase the basis of the acquired inventory to reflect fair value of the inventory and a $230,407 adjustment to decrease the basis of the acquired deferred revenue to reflect the fair value of the deferred revenue at the Acquisition Date.

The goodwill recognized is attributable primarily to expected synergies and the assembled workforce of ISP. None of the goodwill is expected to be deductible for income tax purposes. As of March 31, 2017, there was an adjustment of $713,812 made to the recognized amounts of goodwill to decrease goodwill to reflect changes in the fair value of the net assets purchased in the Acquisition.

The Company recognized approximately $45,000 of Acquisition related costs that were expensed in the current period and approximately $653,000 for the nine months ended March 31, 2017. These costs are included in the consolidated statements of comprehensive income in the line item entitled “Selling, general and administrative.” The Company recognized Acquisition related expenses of approximately $209,000 in fiscal 2016. The Company also recognized approximately $950,000 in expenses associated with the public offering of shares of Class A common stock, the net proceeds of which were used to provide funds to pay for a portion of the purchase price of the Acquisition. These expenses were deducted from the gross proceeds received as a result of the public offering of Class A common stock, as reflected in stockholders’ equity. For additional information on this public offering, see Note 13, Public Offering of Class A Common Stock, in these Consolidated Financial Statements.

The amounts of revenue and net income of ISP included in the Company’s consolidated statements of comprehensive income from the Acquisition Date to the period ending March 31, 2017 are as follows:

Revenue |  | $ | 4,096,286 |
Net income |  | $ | 1,014,923 |

13

The following represents unaudited pro forma consolidated information as if ISP had been included in the consolidated results of the Company for the nine months ending March 31, 2017 and 2016:

|  | Nine months ended |  |  | Nine months ended |
|  | March 31, 2017 |  |  | March 31, 2016 |
Revenue |  | $ | 25,491,276 |  |  | $ | 21,341,435 |
Net income |  | $ | 1,203,355 |  |  | $ | 1,025,228 |

These amounts have been calculated after applying the Company’s accounting policies and adjusting the results for Acquisition expenses and to reflect the additional interest expense and depreciation and amortization that would have been charged assuming the fair value adjustments to property, plant and equipment and intangible assets had been applied on July 1, 2015, together with the consequential tax effects.

Prior to the Acquisition, the Company had a preexisting relationship with ISP. The Company ordered anti-reflective coating services from ISP on an arms’ length basis. The Company had also partnered with ISP to develop and sell molded optics as part of a multiple lens assembly sold to a third party and had provided certain standard molded optics for resale through ISP’s catalog. At the Acquisition Date, the Company had amounts payable to ISP of $8,000 for services provided prior to the Acquisition and ISP had payables of $24,500 due to the Company.

4. Inventories

The components of inventories include the following:

|  | March 31, 2017 |  |  | June 30, 2016 |
Raw materials |  | $ | 2,142,830 |  |  | $ | 1,791,791 |
Work in process |  |  | 1,642,236 |  |  |  | 1,269,539 |
Finished goods |  |  | 2,106,644 |  |  |  | 1,171,343 |
Reserve for obsolescence |  |  | (808,360 | ) |  |  | (395,864 | )
|  | $ | 5,083,350 |  |  | $ | 3,836,809 |

The value of tooling in raw materials was approximately $1.43 million at March 31, 2017 and approximately $1.16 million at June 30, 2016.

14

5. Property and Equipment

Property and equipment are summarized as follows:

|  | Estimated |  |  | March 31, |  |  | June 30, |
|  | Life (Years) |  |  | 2017 |  |  | 2016 |
Manufacturing equipment |  |  | 5 - 10 |  |  | $ | 13,155,843 |  |  | $ | 6,818,382 |
Computer equipment and software |  |  | 3 - 5 |  |  |  | 372,597 |  |  |  | 339,723 |
Furniture and fixtures |  |  | 5 |  |  |  | 107,120 |  |  |  | 92,705 |
Leasehold improvements |  |  | 5 - 7 |  |  |  | 1,212,691 |  |  |  | 1,225,099 |
Construction in progress |  |  |  |  |  |  | 405,338 |  |  |  | 597,452 |
Total property and equipment |  |  |  |  |  |  | 15,253,589 |  |  |  | 9,073,361 |
Less accumulated depreciation and amortization |  |  |  |  |  |  | 5,490,547 |  |  |  | 4,703,316 |
Total property and equipment, net |  |  |  |  |  | $ | 9,763,042 |  |  | $ | 4,370,045 |

6. Accounts Payable

The accounts payable balance as of March 31, 2017 and June 30, 2016 includes approximately $73,000 and $69,250, respectively, which represents earned but unpaid board of directors’ fees.

7. Compensatory Equity Incentive Plan and Other Equity Incentives

Share-Based Compensation Arrangements — The Plan includes several available forms of stock compensation of which incentive stock options and restricted stock awards. Stock based compensation is measured at grant date, based on the fair value of the award, and is recognized as an expense over the employee’s requisite service period. We estimate the fair value of each stock option as of the date of grant using the Black-Scholes-Merton pricing model. Most options granted under the Plan vest ratably over two to four years and generally have ten-year contract lives. The volatility rate is based on four-year historical trends in common stock closing prices and the expected term was determined based primarily on historical experience of previously outstanding options. The interest rate used is the U.S. Treasury interest rate for constant maturities. The likelihood of meeting targets for option grants that are performance based are evaluated each quarter. If it is determined that meeting the targets is probable then the compensation expense will be amortized over the remaining vesting period.

The LightPath Technologies, Inc. Employee Stock Purchase Plan (“2014 ESPP”) was adopted by our board of directors on October 30, 2014 and approved by our stockholders on January 29, 2015.

The 2014 ESPP permits employees to purchase shares of our Class A common stock through payroll deductions, which may not exceed 15% of an employee’s compensation, at a price not less than 85% of the market value of our Class A common stock on specified dates (June 30 and December 31). In no event can any participant purchase more than $25,000 worth of shares of Class A common stock in any calendar year and an employee cannot purchase more than 8,000 shares on any purchase date within an offering period of 12 months and 4,000 shares on any purchase date within an offering period of six months. A discount of $1,927 and $2,303 for the nine months ended March 31, 2017 and 2016, respectively, is included in the selling, general and administrative expense in the accompanying consolidated statements of comprehensive income, which represents the value of the 10% discount given to the employees purchasing stock under the 2014 ESPP Plan.

15

These plans are summarized below:

|  |  |  |  |  | Award Shares |  |  | Available for |
|  |  |  |  |  | Outstanding |  |  | Issuance |
|  |  | Award |  |  | at March 31, |  |  | at March 31, |
| Equity Compensation Arrangement |  | Authorized |  |  | 2017 |  |  | 2017 |
| Amended and Restated Omnibus Incentive Plan |  |  | 3,915,625 |  |  |  | 2,602,968 |  |  |  | 633,701 |
| Employee Stock Purchase Plan |  |  | 400,000 |  |  |  | — |  |  |  | 377,988 |
|  |  |  | 4,315,625 |  |  |  | 2,602,968 |  |  |  | 1,011,689 |

Grant Date Fair Values and Underlying Assumptions; Contractual Terms — We estimate the fair value of each stock option as of the date of grant. We use the Black-Scholes-Merton pricing model. The 2014 ESPP fair value is the amount of the discount the employee obtains at the date of the purchase transaction.

For stock options granted in the nine month periods ended March 31, 2017 and 2016, we estimated the fair value of each stock option as of the date of grant using the following assumptions:

|  | Nine months |  |  | Nine months |
|  | March 31, 2017 |  |  | March 31, 2016 |
Weighted average expected volatility |  |  | 77% - 83% |  |  |  | 68% - 103% |
Dividend yields |  |  | 0% |  |  |  | 0% |
Weighted average risk-free interest rate |  |  | 1.18% - 1.90% |  |  |  | 0.37% - 1.49% |
Weighted average expected term, in years |  |  | 7.49 |  |  |  | 4.29 - 7.50 |

Most options granted under the Plan vest ratably over two to four years and are generally exercisable for ten years. The assumed forfeiture rates used in calculating the fair value of options and restricted stock unit (“RSU”) grants with both performance and service conditions were 20% for each of the nine months ended March 31, 2017 and 2016. The volatility rate and expected term are based on seven-year historical trends in Class A common stock closing prices and actual forfeitures. The interest rate used is the U.S. Treasury interest rate for constant maturities.

16

Information Regarding Current Share-Based Compensation Awards — A summary of the activity for share-based compensation awards in the nine months ended March 31, 2017 is presented below:

|  |  |  |  |  |  |  |  |  |  | Restricted |
|  | Stock Options |  |  | Stock Units (RSUs) |
|  |  |  |  |  |  | Weighted |  |  |  | Weighted |  |  |  |  |  |  |  | Weighted |
|  |  |  |  |  |  | Average |  |  |  | Average |  |  |  |  |  |  |  | Average |
|  |  |  |  |  |  | Exercise |  |  |  | Remaining |  |  |  |  |  |  |  | Remaining |
|  |  |  |  |  |  | Price |  |  |  | Contract |  |  |  |  |  |  |  | Contract |
|  |  | Shares |  |  |  | (per share) |  |  |  | Life (YRS) |  |  |  | Shares |  |  |  | Life (YRS) |
June 30, 2016 |  |  | 819,260 |  |  | $ | 1.90 |  |  |  | 5.6 |  |  |  | 1,311,795 |  |  |  | 0.9 |
Granted |  |  | 339,926 |  |  | $ | 1.61 |  |  |  | 9.6 |  |  |  | 230,772 |  |  |  | 2.6 |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (33,785 | ) |  |  | — |
Cancelled/Forfeited |  |  | (65,000 | ) |  | $ | 4.26 |  |  |  | — |  |  |  | — |  |  |  | — |
March 31, 2017 |  |  | 1,094,186 |  |  | $ | 1.67 |  |  |  | 6.6 |  |  |  | 1,508,782 |  |  |  | 1.0 |
Awards exercisable/vested as of |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
March 31, 2017 |  |  | 850,425 |  |  | $ | 1.70 |  |  |  | 5.9 |  |  |  | 1,069,870 |  |  |  | — |
Awards unexercisable/unvested as of |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
March 31, 2017 |  |  | 243,761 |  |  | $ | 1.56 |  |  |  | 8.8 |  |  |  | 438,912 |  |  |  | 1.0 |
|  |  | 1,094,186 |  |  |  |  |  |  |  |  |  |  |  | 1,508,782 |  |  |  |  |

|  |  | Stock Options |  |  | RSUs |  |  | All Awards |
Weighted average fair value of share awards granted in period |  |  | $ | 1.15 |  |  | $ | 1.56 |  |  | $ | 1.32 |

The total intrinsic value of options outstanding and exercisable at March 31, 2017 and 2016 was $900,135 and $250,348, respectively.

The total intrinsic value of RSUs exercised during the nine months ended March 31, 2017 and 2016 was $79,395 and $0, respectively.

The total intrinsic value of RSUs outstanding and exercisable at March 31, 2017 and 2016 was $2,931,444 and $1,757,796, respectively.

The total fair value of RSUs vested during the nine months ended March 31, 2017 and 2016 was $333,117 and $388,858, respectively.

The total fair value of option shares vested during the nine months ended March 31, 2017 and 2016 was $406,450 and $37,415, respectively.

17

As of March 31, 2017, there was $557,103 of total unrecognized compensation cost related to non-vested share-based compensation arrangements (including share options and restricted stock units) granted under the Plan. We expect to recognize the compensation cost as follows:

|  |  | Stock |  |  |  |  |  |  |
|  |  | Options |  |  | RSUs |  |  | Total |
Three months ended June 30, 2017 |  |  |  | 12,597 |  |  |  | 63,735 |  |  |  | 76,332 |
Year ended June 30, 2018 |  |  |  | 39,612 |  |  |  | 244,917 |  |  |  | 284,529 |
Year ended June 30, 2019 |  |  |  | 17,784 |  |  |  | 144,984 |  |  |  | 162,768 |
Year ended June 30, 2020 |  |  |  | 3,243 |  |  |  | 29,989 |  |  |  | 33,232 |
Year ended June 30, 2021 |  |  |  | 242 |  |  |  | — |  |  |  | 242 |
|  |  | $ | 73,478 |  |  | $ | 483,625 |  |  | $ | 557,103 |

RSU awards vest immediately or from two to four years from the date of grant.

We issue new shares of Class A common stock upon the exercise of stock options. The following table is a summary of the number and weighted average grant date fair values regarding our unexercisable/unvested awards as of March 31, 2017 and changes during the nine months then ended:

Unexercisable/unvested awards |  | Stock Options Shares |  |  | RSU Shares |  |  | Total Shares |  |  | Weighted-Average Grant Date Fair Values (per share) |
June 30, 2016 |  |  | 182,250 |  |  |  | 441,599 |  |  |  | 623,849 |  |  | $ | 1.35 |
Granted |  |  | 339,926 |  |  |  | 230,772 |  |  |  | 570,698 |  |  | $ | 1.32 |
Vested |  |  | (274,665 | ) |  |  | (233,459 | ) |  |  | (508,124 | ) |  | $ | 1.28 |
Cancelled/Forfeited |  |  | (3,750 | ) |  |  | — |  |  |  | (3,750 | ) |  | $ | 1.08 |
March 31, 2017 |  |  | 243,761 |  |  |  | 438,912 |  |  |  | 682,673 |  |  | $ | 1.38 |

Financial Statement Effects and Presentation — The following table shows total stock-based compensation expense for the nine months ended March 31, 2017 and 2016 included in the consolidated statements of comprehensive income:

|  | Nine months ended |  |  | Nine months ended |
|  | March 31, |  |  | March 31, |
|  | 2017 |  |  | 2016 |
Stock options |  | $ | 34,882 |  |  | $ | 37,125 |
RSUs |  |  | 284,300 |  |  |  | 224,490 |
Total |  | $ | 319,182 |  |  | $ | 261,615 |
The amounts above were included in: |  |  |  |  |  |  |  |
Selling, general & administrative |  | $ | 315,429 |  |  | $ | 260,450 |
Cost of sales |  |  | 2,792 |  |  |  | 238 |
New product development |  |  | 961 |  |  |  | 927 |
|  | $ | 319,182 |  |  | $ | 261,615 |

18

8. Foreign Operations

Assets and liabilities denominated in non-U.S. currencies are translated at rates of exchange prevailing on the balance sheet date, and revenues and expenses are translated at average rates of exchange for the period. Gains or losses on the translation of the financial statements of a non-U.S. operation, where the functional currency is other than the U.S. dollar, are reflected as a separate component of equity. The foreign exchange translation adjustment reflects a net gain of approximately $113,000 for the nine months ended March 31, 2017 and a gain of approximately $47,000 for the nine months ended March 31, 2016. As of March 31, 2017, we had approximately $17,993,000 in assets and $16,226,000 in net assets located in China and Latvia. As of June 30, 2016, we had approximately $11,311,000 in assets and $9,942,000 in net assets located in China.

9. Derivative Financial Instruments (Warrant Liability)

On June 11, 2012, we executed a Securities Purchase Agreement with respect to a private placement of an aggregate of 1,943,852 shares of our Class A common stock at $1.02 per share and warrants to purchase up to 1,457,892 shares of our Class A common stock at an initial exercise price of $1.32 per share, which was subsequently reduced to $1.26 and then to $1.22 on December 21, 2016 as a result of our public offering (the “June 2012 Warrants”). The June 2012 Warrants are exercisable for a period of five years beginning on December 11, 2012. We accounted for the June 2012 Warrants issued to investors in accordance with ASC 815-10. ASC 815-10 provides guidance for determining whether an equity-linked financial instrument (or embedded feature) is indexed to an entity’s own stock. This applies to any freestanding financial instrument or embedded feature that has all the characteristics of a derivative under ASC 815-10, including any freestanding financial instrument that is potentially settled in an entity’s own stock.

Due to certain adjustments that may be made to the exercise price of the June 2012 Warrants if we issue or sell shares of our Class A common stock at a price that is less than the then-current warrant exercise price, the June 2012 Warrants have been classified as a liability, as opposed to equity, in accordance with ASC 815-10 as it was determined that the June 2012 Warrants were not indexed to our Class A common stock.

The fair value of the outstanding June 2012 Warrants was re-measured on March 31, 2017 to reflect their fair market value at the end of the current reporting period. As of March 31, 2017, there were 429,195 shares of Class A common stock underlying our outstanding June 2012 Warrants. The June 2012 Warrants will be re-measured at each subsequent financial reporting period until the warrants are either fully exercised or expire. The change in fair value of the June 2012 Warrants is recorded in the statement of comprehensive income and is estimated using the Lattice option-pricing model using the following assumptions:

|  | Exercise |  |  | Exercise |  |  | Exercise |  |  | Exercise |  |  | Exercise |  |  |  |
Inputs into Lattice model for warrants: |  |  | 2/15/2017 |  |  |  | 2/21/2017 |  |  |  | 2/23/2017 |  |  |  | 3/16/2017 |  |  |  | 3/29/2017 |  |  |  | 3/31/2017 |
Equivalent volatility |  |  | 55.28 | % |  |  | 55.02 | % |  |  | 54.17 | % |  |  | 56.93 | % |  |  | 61.04 | % |  |  | 61.47 | %
Equivalent interest rate |  |  | 0.80 | % |  |  | 0.75 | % |  |  | 0.75 | % |  |  | 0.95 | % |  |  | 0.95 | % |  |  | 0.95 | %
Floor |  | $ | 1.15 |  |  | $ | 1.15 |  |  | $ | 1.15 |  |  | $ | 1.15 |  |  | $ | 1.15 |  |  | $ | 1.15 |
Stock price |  | $ | 2.08 |  |  | $ | 2.25 |  |  | $ | 2.27 |  |  | $ | 2.41 |  |  | $ | 2.62 |  |  | $ | 2.74 |
Probability price < strike price |  |  | 24.10 | % |  |  | 24.10 | % |  |  | 23.90 | % |  |  | 13.40 | % |  |  | 13.80 | % |  |  | 5.80 | %
Fair value of call |  | $ | 0.93 |  |  | $ | 1.08 |  |  | $ | 1.09 |  |  | $ | 1.23 |  |  | $ | 1.44 |  |  | $ | 1.55 |
Probability of fundamental transaction occuring |  |  | 0 | % |  |  | 0 | % |  |  | 0 | % |  |  | 0 | % |  |  | 0 | % |  |  | 0 | %

The warrant liabilities are considered recurring Level 3 financial instruments, with a fair value of approximately $665,000 and $717,000 at March 31, 2017 and June 30, 2016, respectively.

19

The following table summarizes the activity of Level 3 instruments measured on a recurring basis for the nine months ended March 31, 2017:

|  | Warrant Liability |
Fair value, June 30, 2016 |  | $ | 717,393 |
Exercise of common stock warrants |  |  | (509,771 | )
Change in fair value of warrant liability |  |  | 457,784 |
Fair value, March 31, 2017 |  | $ | 665,406 |

10. Earnings Per Share

Basic earnings per share is computed by dividing the weighted-average number of shares of Class A common stock outstanding, during each period presented. Diluted earnings per share is computed similarly to basic earnings per share except that it reflects the potential dilution that could occur if dilutive securities or other obligations to issue shares of Class A common stock were exercised or converted into shares of Class A common stock. The computations for basic and diluted earnings per share are described in the following table:

|  | (unaudited) |
|  | Three months ended |  |  | Nine months ended |
|  | March 31, |  |  | March 31, |
|  | 2017 |  |  | 2016 |  |  | 2017 |  |  | 2016 |
Net income |  | $ | 100,824 |  |  | $ | 775,758 |  |  | $ | 1,338,987 |  |  | $ | 1,083,148 |
Basic |  |  | 23,818,136 |  |  |  | 15,530,574 |  |  |  | 18,621,072 |  |  |  | 15,339,337 |
Options to purchase common stock |  |  | 208,429 |  |  |  | 193,488 |  |  |  | 92,094 |  |  |  | 73,737 |
RSUs |  |  | 1,267,572 |  |  |  | 1,102,129 |  |  |  | 1,139,142 |  |  |  | 935,041 |
Common stock warrants |  |  | 334,566 |  |  |  | 577,961 |  |  |  | 293,668 |  |  |  | 495,765 |
Diluted |  |  | 25,628,703 |  |  |  | 17,404,152 |  |  |  | 20,145,976 |  |  |  | 16,843,880 |
Earnings per common share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.00 |  |  | $ | 0.05 |  |  | $ | 0.07 |  |  | $ | 0.07 |
Diluted |  | $ | 0.00 |  |  | $ | 0.04 |  |  | $ | 0.07 |  |  | $ | 0.06 |
Options to purchase common stock |  |  | 883,701 |  |  |  | 631,869 |  |  |  | 868,209 |  |  |  | 708,811 |
RSUs |  |  | 262,983 |  |  |  | 209,666 |  |  |  | 300,096 |  |  |  | 273,553 |
Common stock warrants |  |  | 531,925 |  |  |  | 578,212 |  |  |  | 683,744 |  |  |  | 885,277 |
|  |  | 1,678,609 |  |  |  | 1,419,747 |  |  |  | 1,852,049 |  |  |  | 1,867,641 |

11. Lease Commitments

We have operating leases for office space. At March 31, 2017, we have a lease agreement for our manufacturing and office facility in Orlando, Florida (the “Orlando Lease”). The Orlando Lease, which is for a seven-year original term with renewal options, expires April 2022 and expanded our space to 25,847 square feet, including space added in July 2014. Minimum rental rates for the extension term were established based on annual increases of two and one half percent starting in the third year of the extension period. Additionally, there is one 5-year extension option exercisable by us. The minimum rental rates for such additional extension options will be determined at the time an option is exercised and will be based on a “fair market rental rate” as determined in accordance with the Orlando Lease, as amended.

20

We received approximately $420,000 in a leasehold improvement allowance in fiscal 2015. The improvements were recorded as property and equipment and deferred rent on the consolidated balance sheets. Amortization of leasehold improvements was approximately $111,000 as of March 31, 2017. The deferred rent is being amortized as a reduction in lease expense over the term of the Orlando Lease.

At March 31, 2017, we, through our wholly-owned subsidiary, LPOI, have a lease agreement for an office facility in Shanghai, China (the “Shanghai Lease”). The Shanghai Lease commenced in October 2015 and expires October 2017.

At March 31, 2017, we, through our wholly-owned subsidiary, LPOIZ, have a lease agreement for a manufacturing and office facility in Zhenjiang, China (the “Zhenjiang Lease”). The Zhenjiang Lease, which is for a five-year original term with renewal options, expires March 2019.

At March 31, 2017, we, through our wholly-owned subsidiary ISP, have a lease agreement for a manufacturing and office facility in New York (the “ISP Lease”). The ISP Lease, which is for a five-year original term with renewal options, expires September 2020.

At March 31, 2017, we, through ISP’s wholly-owned subsidiary ISP Latvia, have two lease agreements for a manufacturing and office facility in Riga, Latvia (the “Riga Leases”). The Riga Leases, each of which is for a five-year original term with renewal options, expires December 2019.

During fiscal 2014, 2015 and 2016, we entered into five capital lease agreements, with terms ranging from three to five years, for computer and manufacturing equipment, which are included as part of property and equipment. Assets under capital lease include approximately $749,000 in computer equipment and software and manufacturing equipment, with accumulated amortization of approximately $302,000 as of March 31, 2017. Amortization related to capital lease assets is included in depreciation and amortization expense.

Rent expense totaled approximately $530,000 and $427,000 during the nine months ended March 31, 2017 and 2016, respectively.

The approximate future minimum lease payments under capital and operating leases at March 31, 2017 were as follows:

Fiscal year ending June 30, |  | Capital Leases |  |  | Operating Lease |
2017 |  | $ | 60,929 |  |  | $ | 185,000 |
2018 |  |  | 241,726 |  |  |  | 759,000 |
2019 |  |  | 113,391 |  |  |  | 726,000 |
2020 |  |  | 62,258 |  |  |  | 671,000 |
2021 |  |  | — |  |  |  | 434,000 |
2022 and beyond |  |  | — |  |  |  | 280,000 |
Total minimum payments |  |  | 478,304 |  |  | $ | 3,055,000 |

Less imputed interest |  |  | (44,805 | ) |  |  |  |
Present value of minimum lease payments included in capital lease obligations |  |  | 433,499 |  |  |  |  |
Less current portion |  |  | 239,981 |  |  |  |  |
Non-current portion |  | $ | 193,518 |  |  |  |  |

21

12. Loans Payable

On December 21, 2016, the Company executed the Second Amended and Restated Loan and Security Agreement (the “LSA”) with AvidBank for the Term Loan in the aggregate principal amount of $5 million and a working capital revolving line of credit (the “Revolving Line”). The LSA amends and restates that certain Loan and Security Agreement between the Company and AvidBank dated September 30, 2013, as amended and restated pursuant to that certain Amended and Restated Loan and Security Agreement dated as of December 23, 2014, and as further amended pursuant to that certain First Amendment to Amended and Restated Loan and Security Agreement dated as of December 23, 2015.

The Term Loan is for a five-year term. Pursuant to the LSA, interest on the Term Loan began accruing on December 21, 2016 and is paid monthly for the first six months of the term of the Term Loan. Thereafter, both principal and interest is due and payable in fifty-four (54) monthly installments. The Term Loan bears interest at a per annum rate equal to two percent (2.0%) above the Prime Rate, or 6% at March 31, 2017; provided, however, that at no time shall the applicable rate be less than five and one-half percent (5.50%) per annum. Prepayment is permitted; however, the Company must pay a prepayment fee in an amount equal to (i) 1% of the principal amount of the Term Loan if prepayment occurs on or prior to December 21, 2018, or (ii) 0.75% of the principal amount of the Term Loan if such prepayment occurs after December 21, 2017 but on or prior to December 21, 2018, or (iii) 0.50% of the principal amount of the Term Loan if such prepayment occurs after December 21, 2018 but on or prior to December 21, 2019, or (iv) 0.25% of the principal amount of the Term Loan if such prepayment occurs after December 21, 2019 but on or prior to December 21, 2020. Costs incurred of approximately $72,000 were recorded as a discount on debt and will be amortized over the five-year term of the Term Loan. As of March 31, 2017, approximately $3,900 of the costs incurred were amortized.

Pursuant to the LSA, Avidbank will, in its discretion, make loan advances under the Revolving Line to the Company up to a maximum aggregate principal amount outstanding not to exceed the lesser of (i) One Million Dollars ($1,000,000) or (ii) eighty percent (80%) (the “Maximum Advance Rate”) of the aggregate balance of the Company’s eligible accounts receivable, as determined by AvidBank in accordance with the LSA. AvidBank may, in its discretion, elect to not make a requested advance, determine that certain accounts are not eligible accounts, change the Maximum Advance Rate or apply a lower advance rate to particular accounts and terminate the LSA.

Amounts borrowed under the Revolving Line may be repaid and re-borrowed at any time prior to December 21, 2017, at which time all amounts shall be immediately due and payable. The advances under the Revolving Line bear interest, on the outstanding daily balance, at a per annum rate equal to one percent (1%) above the Prime Rate; provided, however, that at no time shall the applicable rate be less than four and one-half percent (4.5%) per annum. Interest payments are due and payable on the last business day of each month. Payments received with respect to accounts upon which advances are made will be applied to the amounts outstanding under the LSA. There were no borrowings under the Revolving Line during the period. As of March 31, 2017, there was no outstanding balance under the Revolving Line.

The Company’s obligations under the LSA are secured by a first priority secured by a first priority security interest (subject to permitted liens) in cash, U.S. inventory and accounts receivable. In addition, the Company’s wholly-owned subsidiary, Geltech, has guaranteed our obligations under the LSA.

The LSA contains customary covenants, including, but not limited to: (i) limitations on the disposition of property; (ii) limitations on changing our business or permitting a change in control; (iii) limitations on additional indebtedness or encumbrances; (iv) restrictions on distributions; and (v) limitations on certain investments. Additionally, the LSA requires us to maintain a fixed charge coverage ratio (as defined in the LSA) of at least 1:15 to 1:00 and an asset coverage ratio (as defined in the LSA) of at least 1.50 to 1.00. As of March 31, 2017, the Company is in compliance with all covenants.

Late payments are subject to a late fee equal to the lesser of five percent (5%) of the unpaid amount or the maximum amount permitted to be charged under applicable law. Amounts outstanding during an event of default accrue interest at a rate of five percent (5%) above the interest rate applicable immediately prior to the occurrence of the event of default. The LSA contains other customary provisions with respect to events of default, expense reimbursement, and confidentiality.

On December 21, 2016, the Company also entered into the Sellers Note in the aggregate principal amount of $6 million. Pursuant to the Sellers Note, during the period commencing on December 21, 2016 (the “Issue Date”) and continuing until the fifteen month anniversary of the Issue Date (the “Initial Period”), interest will accrue on only the principal amount of the Sellers Note in excess of $2,700,000 at an interest rate equal to ten percent (10%) per annum. After the Initial Period, interest will accrue on the entire unpaid principal amount of the Sellers Note from time to time outstanding, at an interest rate equal to ten percent (10%) per annum. Interest is payable semi-annually in arrears. The term of the Sellers Note is five years, and any unpaid interest and principal, together with any other amounts payable under the Sellers Note, is due and payable on December 21, 2021, the maturity date. The Company may prepay the Sellers Note in whole or in part without penalty or premium. If the Company does not pay any amount payable when due, whether at the maturity date, by acceleration, or otherwise, such overdue amount will bear interest at a rate equal to twelve (12%) per annum from the date of such non-payment until the Company pays such amount in full. The Sellers Note was valued based on the present value of expected cash flows, using a risk-adjusted discount rate of 7.5%. The fair value of the Sellers Note was determined to be approximately $6,327,200 based on the present value of expected future cash flows, using a risk-adjusted discount rate of 7.5%. The Sellers Note is included in Loans payable, less current portion on the consolidated balance sheet. As of March 31, 2017 approximately $34,500 was added to the fair value premium and was amortized. As of March 31, 2017 the amount outstanding under the Sellers Note was $5.7 million, after applying the $292,816 working capital adjustment, as discussed in Note 3 to these Consolidated Financial Statements.

22

In addition, upon the occurrence of a payment default, or any other “event of default,” such as a bankruptcy event or a change of control of the Company, the entire unpaid and outstanding principal balance of the Seller’s Note, together with all accrued and unpaid interest and any and all other amounts payable under the Seller’s Note, will immediately be due and payable.

Future maturities of loans payable are as follows:

Year ended June 30, |  |  | Avidbank Note |  |  | Seller’s Note |  |  | Fair Value |  |  | Debt Costs |  |  | Total |
2017 |  |  | $ | — |  |  |  |  |  |  | $ | (29,254 | ) |  | $ | (3,885 | ) |  | $ | (33,139 | )
2018 |  |  |  | 1,111,500 |  |  |  |  |  |  |  | (78,153 | ) |  |  | (15,545 | ) |  |  | 1,017,802 |
2019 |  |  |  | 1,111,000 |  |  |  |  |  |  |  | 123,452 |  |  |  | (15,545 | ) |  |  | 1,218,907 |
2020 |  |  |  | 1,111,000 |  |  |  |  |  |  |  | 132,751 |  |  |  | (15,545 | ) |  |  | 1,228,206 |
2021 |  |  |  | 1,111,000 |  |  |  |  |  |  |  | 142,749 |  |  |  | (15,545 | ) |  |  | 1,238,204 |
2022 |  |  |  | 555,500 |  |  |  | 5,707,184 |  |  |  | 75,363 |  |  |  | (7,772 | ) |  |  | 6,330,275 |
Total payments |  |  | $ | 5,000,000 |  |  | $ | 5,707,184 |  |  | $ | 366,908 |  |  | $ | (73,837 | ) |  | $ | 11,000,255 |
Less current portion |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 833,750 |
Non-current portion |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 10,166,505 |

13. Public Offering of Class A common stock

On December 16, 2016, the Company entered into an Underwriting Agreement (the “Underwriting Agreement”) with Roth Capital Partners, LLC (“Roth Capital”), as representative of the several underwriters identified therein (collectively, the “Underwriters”), relating to the firm commitment offering of 7,000,000 shares of the Company’s Class A common stock, at a public offering price of $1.21 per share. Under the terms of the Underwriting Agreement, the Company also granted the Underwriters an option, exercisable for 45 days, to purchase up to an additional 1,000,000 shares of Common Stock to cover any over-allotments.

On December 21, 2016, the Company completed its underwritten public offering of 8,000,000 shares of Class A common stock, which included the full exercise by the Underwriters of their option to purchase 1,000,000 shares of Class A common stock to cover over-allotments, at a public offering price of $1.21 per share. The Company realized net proceeds of approximately $8.7 million, after deducting underwriting discounts and commissions and estimated offering expenses. The net proceeds from the offering provided funds for a portion of the purchase price of the Acquisition of ISP, as well as provided funds for the payment of transaction expenses and other costs incurred in connection with the Acquisition.

The offering of the shares of Class A Common Stock was made pursuant to a Registration Statement on Form S-1, as amended (Registration No. 333-213860), which the SEC declared effective on December 15, 2016, and the final prospectus dated December 16, 2016.

14. Goodwill and Intangible Assets

The change in the net carrying amount of goodwill was as follows:

Goodwill at June 30, 2016 |  |  | — |
Additions |  |  |  | 1,227,752 |
Adjustments |  |  |  | (713,812 | )
Goodwill at March 31, 2017 |  |  | $ | 513,940 |

23

The increase in goodwill during the first half of fiscal 2017 was due to the Acquisition of ISP. See Note 3, Acquisition of ISP Optics Corporation, to these Consolidated Financial Statements, for more information.

Intangible assets as a result of the Acquisition of ISP were comprised of:

|  |  |  |  | Amortization through |
Fair value of Intangible assets: |  | Useful life (yrs) |  |  | Gross |  |  | March 31, 2017 |  |  | Net |
Customer relationships |  |  | 15 |  |  | $ | 5,666,000 |  |  | $ | 94,433 |  |  | $ | 5,571,567 |
Backlog |  |  | 2 |  |  |  | 376,000 |  |  |  | 47,001 |  |  |  | 328,999 |
Trade secrets |  |  | 8 |  |  |  | 2,734,000 |  |  |  | 85,438 |  |  |  | 2,648,562 |
Trademark |  |  | 8 |  |  |  | 2,438,000 |  |  |  | 76,187 |  |  |  | 2,361,813 |
Non-compete agreement |  |  | 3 |  |  |  | 21,000 |  |  |  | 1,750 |  |  |  | 19,250 |
|  |  |  |  |  | $ | 11,235,000 |  |  | $ | 304,809 |  |  | $ | 10,930,191 |

Future amortization of intangibles is as follows:

Fiscal year ended: |  |  |  |
| June 30, 2017 |  |  | $ | 304,809 |
| June 30, 2018 |  |  |  | 1,219,237 |
| June 30, 2019 |  |  |  | 1,125,235 |
| June 30, 2020 |  |  |  | 1,027,733 |
| June 30, 2021 |  |  |  | 1,024,233 |
| June 30, 2022 and later |  |  |  | 6,228,944 |
|  |  |  | $ | 10,930,191 |

| 24 |

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by us or on our behalf. All statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Quarterly Report on Form 10-Q for the quarter ended March 31, 2017 (the “Quarterly Report”), other than statements of historical facts, which address activities, events or developments that we expect or anticipate will or may occur in the future, including such things as future capital expenditures, growth, product development, sales, business strategy and other similar matters are forward-looking statements. These forward-looking statements are based largely on our current expectations and assumptions and are subject to a number of risks and uncertainties, many of which are beyond our control. Actual results could differ materially from the forward-looking statements set forth herein as a result of a number of factors, including, but not limited to, limited cash resources and the need for additional financing, our dependence on a few key customers, our ability to transition our business into new markets, our ability to increase sales and manage and control costs and other risks described in our reports on file with the SEC. In light of these risks and uncertainties, all of the forward-looking statements made herein are qualified by these cautionary statements and there can be no assurance that the actual results or developments anticipated by us will be realized. We undertake no obligation to update or revise any of the forward-looking statements contained herein.

The discussions of our results as presented in this Quarterly Report include use of the non-GAAP term “gross margin”, as well as other non-GAAP measures discussed in more detail under the heading “Non-GAAP Financial Measures.” Gross margin is determined by deducting the cost of sales from operating revenue. Cost of sales includes manufacturing direct and indirect labor, materials, services, fixed costs for rent, utilities and depreciation, and variable overhead. Gross margin should not be considered an alternative to operating income or net income, which are determined in accordance with GAAP. We believe that gross margin, although a non-GAAP financial measure is useful and meaningful to investors as a basis for making investment decisions. It provides investors with information that demonstrates our cost structure and provides funds for our total costs and expenses. We use gross margin in measuring the performance of our business and have historically analyzed and reported gross margin information publicly. Other companies may calculate gross margin in a different manner.

Overview

Historical:

We are in the business of manufacturing optical components and higher level assemblies including precision molded glass aspheric optics, proprietary high performance fiber optic collimators, GRADIUM glass lenses and other optical materials used to produce products that manipulate light. All the products we produce enable lasers and imaging devices to function more effectively.

In November 2005, we formed LPOI, a wholly-owned subsidiary, located in Jiading, People’s Republic of China. In December 2013, we formed LPOIZ, a wholly-owned subsidiary located in the New City district, of the Jiangsu province, of the People’s Republic of China. LPOIZ’s 26,000 square foot manufacturing facility serves as our primary manufacturing facility in China and provides a lower cost structure for production of larger volumes of optical components and assemblies. The LPOI facility is primarily used for sales and support functions.

In December 2016, we acquired ISP and its wholly-owned subsidiary ISP Latvia. ISP is a vertically integrated manufacturer offering a full range of infrared products from custom infrared optical elements to catalog and high performance lens assemblies. ISP’s New York facility functions as its global headquarters for operations, while also providing manufacturing capabilities, optical coatings, and optical and mechanical design, assembly, and testing. ISP Latvia is located in Riga, Latvia. It is a manufacturer of high precision optics and offers a full range of infrared products including catalog and custom infrared optics. For additional information, see Note 3, Acquisition of ISP Optics Corporation, to the Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

Product Groups and Markets:

We organized our business based on five product groups: low volume precision molded optics (“LVPMO”), high volume precision molded optics (“HVPMO”), specialty products, infrared products, and non-recurring engineering (“NRE”). Our LVPMO product group consists of precision molded optics with a sales price greater than $10 per lens and is usually sold in smaller lot quantities. Our HVPMO product group consists of precision molded optics with a sales price of less than $10 per lens and is usually sold in larger lot quantities. Our infrared product group is comprised of both molded and turned lens and assemblies and includes all ISP products. Our specialty product group is comprised of value added products such as optical subsystems, assemblies, GRADIUM lenses, and isolators. Our NRE product group consists of those products we develop pursuant to product development agreements we enter into with customers. Typically, customers approach us and request that we develop new products or applications for our existing products to fit their particular needs or specifications. The timing and extent of any such product development is outside of our control.

| 25 |

We currently serve the following major markets: industrial, laser, defense, medical, telecommunications, and instrumentation. Within our product groups, we have various applications that serve these major markets. For example, our HVPMO lenses are typically used in industrial tools, especially in China. Our HVPMO and LVPMO lenses are also used in applications for the telecommunications market, such as cloud computing, video distribution via digital technology, wireless broadband, and machine to machine connection, and, the laser market, such as laser tools, scientific and bench top lasers, and bar code scanners. Our infrared products can also be used in various applications within our major markets. Currently, sales of our infrared products are primarily for customers in the industrial market that use thermal imaging cameras. Our infrared products can also be used for gas sensing devices, spectrometers, night vision systems, automotive driver systems, thermal weapon gun sights, and infrared counter measure systems, among others.

Within the larger overall markets, which are estimated to be in the multi-billions of dollars, we believe there is a market of approximately $1.7 billion for our current products and capabilities. We continue to believe our products will provide significant growth opportunities over the next several years and, therefore, we will continue to target specific applications in each of these major markets. In addition to these major markets, a large percentage of our revenues are derived from sales to unaffiliated companies that purchase our products to fulfill their customer’s orders, as well as unaffiliated companies that offer our products for sale in their catalogs. Our strategy is to leverage our technology, know-how, established low cost manufacturing capability and partnerships to grow our business.

Results of Operations

Fiscal Third Quarter: Three months ended March 31, 2017 compared to the three months ended March 31, 2016

Revenues:

Revenue for the third quarter of fiscal 2017 was approximately $8.5 million, an increase of approximately $4.4 million, or 106%, as compared to the same period of the prior fiscal year. The increase from the third quarter of the prior fiscal year is attributable to an approximately $3.5 million increase, or 893%, in revenues generated by infrared products, primarily attributable to ISP, an approximately $1.2 million increase, or 132%, in sales of HVPMO lenses, which was partially offset by an approximately $323,000 decrease, or 38%, in revenues from specialty products and an approximately $30,000 decrease, or 17%, in revenues from NRE projects. The decrease in revenues generated by the specialty products group was due to the absence of approximately $272,000 of revenues generated in the third quarter of fiscal 2016 for a final order of custom fiber collimator assemblies. This specific product technology was transferred to the customer pursuant to a license agreement entered into in fiscal 2015. Thus, the customer is no longer placing orders for fiber collimator assemblies with us.

Cost of Sales and Gross Margin:

Gross margin in the third quarter of fiscal 2017 was $4.2 million, an increase of 90% as compared to $2.2 million in the prior year period. Gross margin as a percentage of revenue was 50% for the third quarter of fiscal 2017, compared to 54% for the third quarter of fiscal 2016. The change in gross margin as a percentage of revenue is primarily attributable to the inclusion of revenues generated by ISP products for the full quarter. Total cost of sales was approximately $4.3 million for the third quarter of fiscal 2017, an increase of approximately $2.4 million as compared to the same period of the prior fiscal year. This increase in total cost of sales is entirely due to the increase in volume of sales, primarily as a result of the Acquisition of ISP.

Selling, General and Administrative:

During the third quarter of fiscal 2017, selling, general and administrative (“SG&A”) costs were approximately $2.3 million, compared to $1.8 million in the third quarter of fiscal 2016, an increase of approximately $517,000 primarily attributable to the addition of ISP’s SG&A costs. The increase was primarily due to an approximately $292,000 increase in wages, an approximately $116,000 increase in professional fees, an approximately $71,000 increase in travel expenses and an approximately $45,000 increase in expenses related to the Acquisition of ISP. We expect future SG&A costs to increase slightly during the remainder of fiscal 2017 due to the addition of ISP’s SG&A costs.

| 26 |

New Product Development:

New product development costs were approximately $308,000 in the third quarter of fiscal 2017, an increase of $143,000, or 87%, as compared to the third quarter of fiscal 2016. This increase was primarily due to an approximately $116,000 increase in wages, an approximately $15,000 increase in patent expenses, an approximately $6,000 increase in materials used for engineering projects and an approximately $6,000 increase in other expenses. We anticipate that these expenses will remain at current levels for the remainder of fiscal year 2017.

Other Income (Expense):

Interest expense was approximately $193,000 in the third quarter of fiscal 2017 as compared to approximately $8,000 in the third quarter of fiscal 2016. Interest expense resulted from (i) amortization of debt costs related to our prior invoiced-based working capital revolving line of credit with Avidbank pursuant to that certain Amended and Restated Loan and Security Agreement dated December 23, 2014, as further amended by that First Amendment to Amended and Restated Loan Security Agreement dated December 23, 2015 (collectively, the “Prior Line of Credit”), (ii) interest on the Term Loan and the Sellers Note and (iii) interest on capital leases.

In the third quarter of fiscal 2017, we recognized non-cash expense of approximately $748,000 related to the change in the fair value of warrant liability in connection with our June 2012 Warrants. We recognized income of approximately $662,000 in the same period last year. The change in fair value of the June 2012 Warrants is not impacted by our actual operations but is instead strongly tied to the change in market value of our Class A common stock. This fair value will be re-measured each reporting period throughout the remainder of the five-year life of the June 2012 warrants, or until exercised.

Other income, net was approximately $28,000 in the third quarter of fiscal 2017 compared to approximately $36,000 in the third quarter of fiscal 2016. We execute all foreign sales from our Orlando and New York facilities and inter-company transactions in United States dollars, mitigating the impact of foreign currency fluctuations. Assets and liabilities denominated in non-United States currencies, primarily the Chinese Yuan and Euro, are translated at rates of exchange prevailing on the balance sheet date, and revenues and expenses are translated at average rates of exchange for the year. During the third quarter of fiscal 2017 and 2016, we incurred a gain of approximately $18,000 and $26,000, respectively, on foreign currency translation.

Income taxes:

Income tax expense was approximately $266,000 in the third quarter of fiscal 2017, an increase of $139,000 compared to the third quarter of fiscal 2016. This increase was primarily attributable to income taxes associated with our Chinese subsidiaries and, to a much lesser extent, income taxes attributable to ISP Latvia. We extinguished all net operating loss (“NOL”) carryforwards in China during fiscal 2016. Accordingly, we are now accruing income taxes in China related to such operations. Our Chinese subsidiaries are governed by the Income Tax Law of the People’s Republic of China, which is applicable to privately run and foreign invested enterprises, and which generally subjects such enterprises to a statutory rate of 25% on income reported in the statutory financial statements after appropriate tax adjustments. ISP Latvia is governed by the Law of Corporate Income Tax of Latvia, which is applicable to privately run and foreign invested enterprises, and which generally subjects such enterprises to a statutory rate of 15% on income reported in the statutory financial statements after appropriate tax adjustments. We anticipate that these expenses will remain at current levels for the remainder of fiscal year 2017.

Our effective tax rate was 71% for the third quarter of 2017. Excluding the impact of the change in the fair value of the warrant liability and the impact of foreign translation, which are both excluded when computing taxable income, our effective tax rate was 24%. This is a blending of the Chinese statutory rate of 25% and the Latvian statutory rate of 15%.

Net Income:

Net income was approximately $101,000, or $0.00 basic and diluted earnings per share, during the third quarter of fiscal 2017, compared with the third quarter of fiscal 2016, in which we reported a net income of approximately $776,000, or $0.05 basic and $0.04 diluted earnings per share. The approximately $675,000 decrease in net income in the third quarter of fiscal 2017, as compared to the prior year period, is primarily as a result of the recognition of approximately $748,000 in non-cash expense associated with the change in the fair value of the warrant liability in connection with our June 2012 Warrants. In the comparable prior period, the change in warrant liability resulted in non-cash income of approximately $662,000. The change in warrant liability between periods of approximately $1.4 million is offset by an approximately $1.1 million increase in operating income as a result of the approximately $4.4 million increase in revenue. Net income was also affected by higher income taxes, as well as an increase in SG&A expenses and new product development costs in the third quarter of fiscal 2017 as compared to the prior year period. Approximately 73% of the increase in SG&A expenses in the third quarter of fiscal 2017, as compared to the prior year period, was related to the Acquisition of ISP.

Weighted-average basic and diluted common shares outstanding increased to 23,818,136 and 25,628,703, respectively, in the third quarter of fiscal 2017 from 15,530,574 and 17,404,152, respectively, in the third quarter of fiscal 2016. The increase was primarily due to 8 million shares of Class A common stock issued in connection with the Acquisition of ISP, shares of Class A common stock issued under the 2014 ESPP and shares of Class A common stock issued as a result of the exercises of stock options and warrants.

| 27 |

Fiscal First Nine Months: Nine months ended March 31, 2017 compared to the nine months ended March 31, 2016

Revenues:

Revenue for the first nine months of fiscal 2017 was approximately $19.4 million, an increase of approximately $6.8 million, or 54%, as compared to the same period of the prior fiscal year. The increase from the first nine months of the prior fiscal year is attributable to an approximately $4.2 million increase, or 375%, in revenues generated primarily by sales of ISP’s infrared lenses, an approximately $3.2 million increase, or 121%, in revenues generated by sales of HVPMO lenses, and an approximately $888,000 increase, or 17%, in revenues generated by sales of LVPMO lenses, partially offset by an approximately $ 1.2 million decrease, or 40%, in revenues from specialty products and an approximately $166,000 decrease, or 32%, in revenues from NRE projects. The decrease in revenues generated by the specialty products group was due to the absence of approximately $1.0 million of revenues generated in the first nine months of fiscal 2016 due to a final order of custom fiber collimator assemblies. This specific product technology was transferred to the customer pursuant to a license agreement entered into in fiscal 2015. Thus, the customer is no longer placing orders for fiber collimator assemblies with us.

Cost of Sales and Gross Margin:

Gross margin as a percentage of revenue in the first nine months of fiscal 2017 was 53%, compared to 55% in the first nine months of fiscal 2016. Gross profit in the first nine months of fiscal 2017 was $10.4 million, compared to $6.8 million in the prior year period, an increase of 51%. Total cost of sales was approximately $9.0 million for the first nine months of fiscal 2017, an increase of approximately $3.3 million compared to the same period of the prior fiscal year. The 58% increase in cost of sales was entirely due to the increased volume, primarily as a result of the Acquisition of ISP.

Selling, General and Administrative:

During the first nine months of fiscal 2017, SG&A costs were approximately $6.2 million, compared to $4.8 million in the first nine months of fiscal 2016, an increase of approximately $1.4 million. The increase was primarily due to: (i) an approximately $653,000 increase in expenses related to the Acquisition of ISP, (ii) an approximately $107,000 increase in travel expenses, (iii) an approximately $173,000 increase in professional fees, (iv) an approximately $389,000 increase in wages, primarily related to the Acquisition of ISP, and (v) an approximately $78,000 increase in other expenses. We expect future SG&A costs to increase slightly during the remainder of fiscal 2017 due to the addition of ISP’s SG&A costs.

New Product Development:

New product development costs were approximately $854,000 in the first nine months of fiscal 2017, an increase of approximately $373,000 as compared to the first nine months of fiscal 2016. This increase was primarily due to an approximately $291,000 increase in wages, an approximately $55,000 increase in materials used for engineering projects to expand and enhance our existing products and an approximately $26,000 increase in other expenses. We anticipate that these expenses will remain at current levels for the remainder of fiscal year 2017.

Other Income (Expense):

Interest expense was approximately $206,000 in the first nine months of fiscal 2017 as compared to approximately $30,000 in the first nine months of fiscal 2016. Interest expense resulted from (i) amortization of debt costs related to our Prior Line of Credit with Avidbank, (ii) interest on Term Loan and the Sellers Note, and (iii) interest on capital leases.

In the first nine months of fiscal 2017, we recognized non-cash expense of approximately $458,000 related to the change in the fair value of warrant liability in connection with our June 2012 Warrants. We recognized expense of approximately $25,000 in the same period last year. The change in fair value of the June 2012 warrants is not impacted by our actual operations but is instead strongly tied to the change in market value of our Class A common stock. This fair value will be re-measured each reporting period throughout the remainder of the five-year life of the warrants, or until exercised.

Other expense, net was approximately $229,000 in the first nine months of fiscal 2017 compared to approximately $217,000 in the first nine months of fiscal 2016. We execute all foreign sales from our Orlando and New York facilities and inter-company transactions in United States dollars, mitigating the impact of foreign currency fluctuations. Assets and liabilities denominated in non-United States currencies, primarily the Chinese Yuan and Euro, are translated at rates of exchange prevailing on the balance sheet date, and revenues and expenses are translated at average rates of exchange for the year. During the first nine months of fiscal 2017 and 2016, we incurred a loss of approximately $254,000 and $176,000, respectively, on foreign currency translation.

| 28 |

Income taxes:

Income tax expense was approximately $772,000 in the first nine months of fiscal 2017, an increase of $641,000 from the first nine months of fiscal 2016. This increase was primarily attributable to income taxes associated with our Chinese operations, and to a much lesser extent income taxes attributable to ISP Latvia. We utilized all NOL carryforwards in China during fiscal 2016. Accordingly, we are now accruing income taxes in China related to such operations. Our Chinese subsidiaries are governed by the Income Tax Law of the People’s Republic of China, which is applicable to privately run and foreign invested enterprises, and which generally subjects such enterprises to a statutory rate of 25% on income reported in the statutory financial statements after appropriate tax adjustments. ISP Latvia is governed by the Law of Corporate Income Tax of Latvia, which is applicable to privately run and foreign invested enterprises, and which generally subjects such enterprises to a statutory rate of 15% on income reported in the statutory financial statements after appropriate tax adjustments. We anticipate that these expenses will remain at current levels for the remainder of fiscal year 2017.

Our effective tax rate was 37% for the first nine months of 2017. During the first quarter of fiscal 2017, we determined that income tax expense was understated for fiscal 2016 by approximately $74,000. We determined that the error was not material to the prior year financial statements. We also concluded that an out-of-period correction would not be material and therefore have corrected this error in the first nine months of fiscal 2017. Excluding the impact of the out-of-period correction, the change in the fair value of the warrant liability and the impact of foreign translation, which are both excluded when computing taxable income, our effective tax rate was 25%.

Net Income:

Net income was approximately $1.3 million, or $0.07 basic and diluted earnings per share, during the first nine months of fiscal 2017, compared with the first nine months of fiscal 2016, in which we reported net income of approximately $1.1 million, or $0.07 basic and $0.06 diluted earnings per share. Net income was affected by the increase in operating expenses in the first nine months of fiscal 2017 as compared to the prior year period, including higher SG&A expenses and product development costs, and an approximately $653,000 increase in expenses as a result of expenses incurred related to the Acquisition of ISP.

Weighted-average basic and diluted common shares outstanding increased to 18,621,072 and 20,145,976, respectively, in the first nine months of fiscal 2017 from 15,339,337 and 16,843,880, respectively, in the first nine months of fiscal 2016. The increase was primarily due to 8 million shares of Class A common stock issued in connection with the Acquisition of ISP, shares of Class A common stock issued under the 2014 ESPP and shares of Class A common stock issued as a result of exercises of stock options and warrants.

Liquidity and Capital Resources

At March 31, 2017, we had working capital of approximately $13.0 million and total cash and cash equivalents of approximately $6.8 million, of which approximately $3.6 million of total cash and cash equivalents were held by our foreign subsidiaries.

Cash and cash equivalents held by our foreign subsidiaries were generated in China and Latvia as a result of foreign earnings. Before any funds can be repatriated from China, the retained earnings in China must equal at least 150% of the registered capital. As of March 31, 2017, we had retained earnings of $3.3 million and we need to have $11.3 million before repatriation will be allowed. We currently intend to permanently invest earnings from foreign operations, and therefore, we have not previously provided United States taxes on the related earnings. We would provide for and pay additional United States taxes at such time.

On December 21, 2016, we executed the LSA with AvidBank for the Term Loan in the aggregate principal amount of $5 million and the Revolving Line. The LSA amends and restates that certain Loan and Security Agreement between us and AvidBank dated September 30, 2013, as amended and restated pursuant to that certain Amended and Restated Loan and Security Agreement dated as of December 23, 2014, and as further amended pursuant to that certain First Amendment to Amended and Restated Loan and Security Agreement dated as of December 23, 2015.

The Term Loan is for a five-year term. Pursuant to the LSA, interest on the Term Loan began accruing on December 21, 2016 and is paid monthly for the first six months of the term of the Term Loan. Thereafter, both principal and interest is due and payable in fifty-four (54) monthly installments. The Term Loan bears interest at a per annum rate equal to two percent (2.0%) above the Prime Rate; provided, however, that at no time shall the applicable rate be less than five and one-half percent (5.50%) per annum. Prepayment is permitted; however, we must pay a prepayment fee in an amount equal to (i) 1% of the principal amount of the Term Loan if prepayment occurs on or prior to December 21, 2018, or (ii) 0.75% of the principal amount of the Term Loan if such prepayment occurs after December 21, 2017 but on or prior to December 21, 2018, or (iii) 0.50% of the principal amount of the Term Loan if such prepayment occurs after December 21, 2018 but on or prior to December 21, 2019, or (iv) 0.25% of the principal amount of the Term Loan if such prepayment occurs after December 21, 2019 but on or prior to December 21, 2020.

| 29 |

Pursuant to the LSA, Avidbank will, in its discretion, make loan advances under the Revolving Line to us up to a maximum aggregate principal amount outstanding not to exceed the lesser of (i) One Million Dollars ($1,000,000) or (ii) the Maximum Advance Rate of the aggregate balance of our eligible accounts receivable, as determined by AvidBank in accordance with the LSA. AvidBank may, in its discretion, elect to not make a requested advance, determine that certain accounts are not eligible accounts, change the Maximum Advance Rate or apply a lower advance rate to particular accounts and terminate the LSA.

Amounts borrowed under the Revolving Line may be repaid and re-borrowed at any time prior to December 21, 2017, at which time all amounts shall be immediately due and payable. The advances under the Revolving Line bear interest, on the outstanding daily balance, at a per annum rate equal to one percent (1%) above the Prime Rate; provided, however, that at no time shall the applicable rate be less than four and one-half percent (4.5%) per annum. Interest payments are due and payable on the last business day of each month. Payments received with respect to accounts upon which advances are made will be applied to the amounts outstanding under the LSA.

The Company’s obligations under the LSA are secured by a first priority secured by a first priority security interest (subject to permitted liens) in cash, U.S. inventory and accounts receivable. In addition, the Company’s wholly-owned subsidiary, Geltech, has guaranteed our obligations under the LSA.

The LSA contains customary covenants, including, but not limited to: (i) limitations on the disposition of property; (ii) limitations on changing our business or permitting a change in control; (iii) limitations on additional indebtedness or encumbrances; (iv) restrictions on distributions; and (v) limitations on certain investments.

Late payments are subject to a late fee equal to the lesser of five percent (5%) of the unpaid amount or the maximum amount permitted to be charged under applicable law. Amounts outstanding during an event of default accrue interest at a rate of five percent (5%) above the interest rate applicable immediately prior to the occurrence of the event of default.

As of March 31, 2017, the amount outstanding under the Term Loan was $5 million and under the Revolving Line was $0. Costs incurred of approximately $72,000 were recorded as a discount on debt and will be amortized over the five-year term of the Loan. Amortization of approximately $3,900 is included in interest expense.

On December 21, 2016, we also entered into a Sellers Note in the aggregate principal amount of $6 million. Pursuant to the Sellers Note, during the Initial Period, interest will accrue on only the principal amount of the Sellers Note in excess of $2,700,000 at an interest rate equal to ten percent (10%) per annum. After the Initial Period, interest will accrue on the entire unpaid principal amount of the Sellers Notes from time to time outstanding, at an interest rate equal to ten percent (10%) per annum. Interest is payable semi-annually in arrears. The term of the Sellers Note is five years, and any unpaid interest and principal, together with any other amounts payable under the Sellers Note, is due and payable on the maturity date. We may prepay the Sellers Note in whole or in part without penalty or premium. If we do not pay any amount payable when due, whether at the maturity date, by acceleration, or otherwise, such overdue amount will bear interest at a rate equal to twelve (12%) per annum from the date of such non-payment until we pay such amount in full. The fair value of the Sellers Note was determined to be approximately $6,327,200. The fair value of the future payments was determined using the risk adjusted rate of 7.5%. The Sellers Note is included in Loans payable, less current portion on the consolidated balance sheet.

In addition, upon the occurrence of a payment default, or any other “event of default,” such as a bankruptcy event or a change of control of us, the entire unpaid and outstanding principal balance of the Sellers Note, together with all accrued and unpaid interest and any and all other amounts payable under the Sellers Note, will immediately be due and payable.

As of March 31, 2017, the amount outstanding under the Sellers Note was $5.7 million, after applying the approximately $292,800 working adjustment to the balance.

For additional information, see Note 12, Loans Payable, to the Notes to the Consolidated Financial Statements to this Quarterly Report on Form 10-Q.

| 30 |

We believe that we have adequate financial resources to sustain our current operations in the coming year. We have established milestones that will be tracked to ensure that as funds are expended we are achieving results before additional funds are committed. We anticipate sales growth during the remainder of fiscal 2017 primarily from precision molded optics, with the emphasis on HVPMO applications, specialty products, and infrared products, particularly as a result of the ISP Acquisition. We also expect to be better positioned to accelerate our revenue growth and profitability as a result of our transition to a technical sales process that leverages the success of our existing demand-creation model. These growth initiatives and organizational modifications are intended to further enhance our incremental organic growth position for our core aspheric lens business, prime our operations for the anticipated high growth of our new infrared products, and allow for the integration of strategic acquisitions. We are also benefiting from a substantial increase in revenue generating opportunities and broader market applications as a result of our investments in technologies that decreased our lens production costs and expanded our production capacity. We believe we can further improve upon our track record of growth – and do so far more profitably.

We generally rely on cash from operations and equity and debt offerings, to the extent available, to satisfy our liquidity needs. There are a number of factors that could result in the need to raise additional funds, including a decline in revenue or a lack of anticipated sales growth, increased material costs, increased labor costs, planned production efficiency improvements not being realized, increases in property, casualty, benefit and liability insurance premiums, and increases in other discretionary spending, particularly sales and marketing related. We will also continue efforts to keep costs under control as we seek renewed sales growth. Our efforts continue to be directed toward maintaining positive cash flow and profitability. If our efforts are not successful, we will need to raise additional capital. Should capital not be available to us at reasonable terms, other actions may become necessary in addition to cost control measures and continued efforts to increase sales. These actions may include exploring strategic options for the sale of the Company, the sale of certain product lines, the creation of joint ventures or strategic alliances under which we will pursue business opportunities, the creation of licensing arrangements with respect to our technology, or other alternatives.

Cash Flows – Financings:

Net cash provided by financing activities was approximately $14.1 million in the first nine months of fiscal 2017 compared to a net cash provided of approximately $272,000 in the first nine months of fiscal 2016. We received approximately $5.0 million in proceeds from the Loan and approximately $8.7 million in net proceeds related to the public offering of 8,000,000 shares of our Class A common stock in connection with the Acquisition of ISP. We also received net proceeds of approximately $585,000 from the exercise of June 2012 Warrants in the first nine months of fiscal 2017.

Cash Flows – Operating and Investing:

Cash flow provided by operations was approximately $2.9 million for the nine months ended March 31, 2017, compared to $1.2 million for the first nine months of fiscal 2016. We anticipate improvement in our cash flows provided by operations in future years due to sales growth, particularly as a result of the Acquisition of ISP, and continued margin improvements based on production efficiencies and reductions in product costs, offset by marginal increases in selling, administrative, and new product development expenditures.

Overall, during the first nine months of fiscal 2017, we expended approximately $13.2 million in investing activities, compared to approximately $750,000 in the first nine months of fiscal 2016. During the first nine months of fiscal 2017, we expended approximately $1.4 million for capital equipment as compared to $756,000 during the same period of fiscal 2016. The majority of our capital expenditures during both of the nine month periods of fiscal 2017 and fiscal 2016 were related to the purchase of equipment used to enhance or expand our production capacity, tooling for our precision molded products, and equipment and facility improvements for our facility in Zhenjiang. Overall, we anticipate an increase in capital expenditures during fiscal 2017, as compared to fiscal 2016; however, the total amount expended will depend on opportunities and circumstances.

During the first nine months of fiscal 2017, we also expended approximately $11.8 million for the Acquisition of ISP, see Note 3 for more information.

| 31 |

How we operate:

We have continuing sales of two basic types: occasional sales via ad-hoc purchase orders of mostly standard product configurations (our “turns” business) and the more challenging and potentially more rewarding business of customer product development. In this latter type of business we work with customers to help them determine optical specifications and even create certain optical designs for them, including complex multi-component designs that we call “engineered assemblies”. This is followed by “sampling” small numbers of the product for the customers’ test and evaluation. Thereafter, should a customer conclude that our specification or design is the best solution to their product need; we negotiate and “win” a contract (sometimes called a “design win”) – whether of a “blanket purchase order” type or a supply agreement. The strategy is to create an annuity revenue stream that makes the best use of our production capacity as compared to the turns business, which is unpredictable and uneven. This annuity revenue stream can also generate low-cost, high-volume type orders. A key business objective is to convert as much of our business to the design win and annuity model as is possible. We face several challenges in doing so:

| ● | Maintaining an optical design and new product sampling capability, including a high-quality and responsive optical design engineering staff;

| ● | The fact that as our customers take products of this nature into higher volume, commercial production (for example, in the case of molded optics, this may be volumes over one million pieces per year) they begin to work seriously to reduce costs – which often leads them to turn to larger or overseas producers, even if sacrificing quality; and

| ● | Our small business mass means that we can only offer a moderate amount of total productive capacity before we reach financial constraints imposed by the need to make additional capital expenditures – in other words, because of our limited cash resources and cash flow, we may not be able to service every opportunity that presents itself in our markets without arranging for such additional capital expenditures.

Despite these challenges to winning more “annuity” business, we nevertheless believe we can be successful in procuring this business because of our unique capabilities in optical design engineering that we make available on the merchant market, a market that we believe is underserved in this area of service offering. Additionally, we believe that we offer value to some customers as a source of supply in the United States should they be unwilling to commit their entire source of supply of a critical component to foreign merchant production sources. We also continue to have the proprietary GRADIUM lens glass technology to offer to certain laser markets.

Our key indicators:

Usually on a weekly basis, management reviews a number of performance indicators. Some of these indicators are qualitative and others are quantitative. These indicators change from time to time as the opportunities and challenges in the business change. They are mostly non-financial indicators such as units of shippable output by product line, production yield rates by major product line and the output and yield data from significant intermediary manufacturing processes that support the production of the finished shippable product. These indicators can be used to calculate such other related indicators as fully yielded unit production per-shift, which varies by the particular product and our state of automation in production of that product at any given time. Higher unit production per shift means lower unit cost and therefore improved margins or improved ability to compete where desirable for price sensitive customer applications. The data from these reports is used to determine tactical operating actions and changes. We believe that our non-financial production indicators, such as those noted, are proprietary information.

Financial indicators that are usually reviewed at the same time include the major elements of the micro-level business cycle:

| ● | sales backlog;

| ● | revenue dollars and units by product group;

| ● | inventory levels;

| ● | accounts receivable levels and quality; and

| ● | other key indicators.

These indicators are similarly used to determine tactical operating actions and changes and are discussed in more detail below.

Sales Backlog:

Sales growth has been and continues to be our best indicator of success. Our best view into the efficacy of our sales efforts is in our “order book.” Our order book equates to sales “backlog.” It has a quantitative and a qualitative aspect: quantitatively, our backlog’s prospective dollar value and qualitatively, what percent of the backlog is scheduled by the customer for date-certain delivery. We define our “12-month backlog” as that which is requested by the customer for delivery within one year and which is reasonably likely to remain in the backlog and be converted into revenues. This includes customer purchase orders and may include amounts under supply contracts if they meet the aforementioned criteria. Generally, a higher 12-month backlog is better for us.

| 32 |

Our 12-month backlog at March 31, 2017 was approximately $11.1 million compared to $6.6 million as of June 30, 2016. Backlog growth rates for the last five fiscal quarters are:

Quarter |  |  | Backlog ($000) |  |  | Change from Prior Year End |  |  | Change fFrom Prior Quarter End |
Q3 2016 |  |  | $ | 6,969 |  |  |  | 7 | % |  |  | 8 | %
Q4 2016 |  |  | $ | 6,598 |  |  |  | 2 | % |  |  | -5 | %
Q1 2017 |  |  | $ | 5,806 |  |  |  | -12 | % |  |  | -12 | %
Q2 2017 |  |  | $ | 12,422 |  |  |  | 88 | % |  |  | 114 | %
Q3 2017 |  |  | $ | 11,086 |  |  |  | 68 | % |  |  | -11 | %

Our 12-month backlog as of March 31, 2017 includes approximately $6.6 million attributable to ISP.

We have diversified our business by developing new applications for our products in markets such as digital imaging, laser tools, telecommunications, digital projectors, industrial equipment, weapon sights, medical instruments and green lasers. Examples of these new applications include: 2D scanning, fiber laser delivery systems, disposable medical instruments, and infrared sensor applications. With the Acquisition of ISP, we have broadened our capabilities to include additional glass types and the ability to make much larger lenses. Based on recent quote activity, we expect to show increases in revenue of our LVPMOs, HVPMOs, specialty products and infrared products for the remainder of fiscal 2017.

Revenue Dollars and Units by Product Group:

The following table sets forth revenue dollars and units for our five product groups for the three and nine month periods ended March 31, 2017 and 2016:

|  |  |  |  | (unaudited) |
|  |  |  |  | Three months ended |  |  |  |  |  | Nine months ended |  |  |  |
|  |  |  |  | March 31, |  |  | QTR % |  |  | March 31, |  |  | Year-to-date |
|  |  |  |  | 2017 |  |  | 2016 |  |  | Change |  |  | 2017 |  |  | 2016 |  |  | % Change |
Revenue |  |  | LVPMO |  |  | 1,845,799 |  |  |  | 1,786,187 |  |  |  | 3 | % |  |  | 6,144,020 |  |  |  | 5,255,641 |  |  |  | 17 | %
|  |  | HVPMO |  |  | 2,138,911 |  |  |  | 923,896 |  |  |  | 132 | % |  |  | 5,763,849 |  |  |  | 2,607,496 |  |  |  | 121 | %
|  |  | Infrared Products |  |  | 3,843,335 |  |  |  | 386,959 |  |  |  | 893 | % |  |  | 5,280,926 |  |  |  | 1,111,901 |  |  |  | 375 | %
|  |  | Speciality Products |  |  | 516,123 |  |  |  | 838,984 |  |  |  | -38 | % |  |  | 1,826,278 |  |  |  | 3,052,947 |  |  |  | -40 | %
|  |  | NRE |  |  | 145,875 |  |  |  | 175,947 |  |  |  | -17 | % |  |  | 345,036 |  |  |  | 510,649 |  |  |  | -32 | %
|  |  | Total sales, net |  |  | 8,490,043 |  |  |  | 4,111,973 |  |  |  | 106 | % |  |  | 19,360,109 |  |  |  | 12,538,634 |  |  |  | 54 | %
Units |  |  | LVPMO |  |  | 76,788 |  |  |  | 79,075 |  |  |  | -3 | % |  |  | 274,006 |  |  |  | 218,087 |  |  |  | 26 | %
|  |  | HVPMO |  |  | 488,069 |  |  |  | 312,657 |  |  |  | 56 | % |  |  | 1,568,544 |  |  |  | 1,059,849 |  |  |  | 48 | %
|  |  | Infrared Products |  |  | 42,411 |  |  |  | 8,539 |  |  |  | 397 | % |  |  | 64,451 |  |  |  | 19,744 |  |  |  | 226 | %
|  |  | Speciality Products |  |  | 23,857 |  |  |  | 10,027 |  |  |  | 138 | % |  |  | 72,404 |  |  |  | 93,011 |  |  |  | -22 | %
|  |  | NRE |  |  | 27 |  |  |  | 412 |  |  |  | -93 | % |  |  | 55 |  |  |  | 454 |  |  |  | -88 | %
|  |  |  |  |  | 631,152 |  |  |  | 410,710 |  |  |  | 54 | % |  |  | 1,979,460 |  |  |  | 1,391,145 |  |  |  | 42 | %

Three months ended March 31, 2017

Our revenue increased by 106% in the third quarter of fiscal 2017, as compared to the prior year period with growth driven predominantly from the HVPMO and infrared product groups. We have seen strong growth in our core business from the telecommunications sector, and our infrared business has expanded significantly with the Acquisition of ISP.

We had a 3% increase in revenue in LVPMO in the third quarter of fiscal 2017, compared to the same period of the prior fiscal year. Although our unit shipment volume in LVPMO lenses decreased by 3% in the third quarter of fiscal 2017, as compared to the same period of the prior fiscal year, the average selling price increased by 6%, comparatively, due to market conditions. The increase in revenue is attributed to growth in sales to customers in the defense, telecommunications and industrial sectors.

The HVPMO product group benefitted from the strength in the telecommunications sector as the demand for increased bandwidth continues. During the third quarter of fiscal 2017, sales of HVPMO lens units increased by 56%, and the average selling price increased by 48%, both as compared to the prior period, which produced a 132% increase in HVPMO revenue as compared to the prior year period. The increases are due to the continued strength of the telecommunications sector.

| 33 |

We had significant growth in the infrared product group, which primarily consisted of revenues generated by ISP. During the third quarter of fiscal 2017, sales of infrared units increased by 397% as compared to the prior year period, resulting in infrared product revenue increasing by 893% in the third quarter of fiscal 2017 as compared to the prior year period. The increases in revenue and units sold primarily derived from sales to customers in the thermal market.

In the third quarter of fiscal 2017, our specialty product revenue decreased by 38%, as compared to the prior year period. The decrease in revenue is due to revenues generated in the prior period from the sales of our fiber collimator assemblies sold to a customer pursuant to a license agreement, which did not continue in the current period. Approximately $272,000 of the specialty group sales from the third quarter of fiscal 2016 was due to a final order of custom fiber collimator assemblies. This specific product technology was transferred to the customer pursuant to a license agreement entered into in fiscal 2015. Thus, the customer is no longer placing orders for fiber collimator assemblies with us.

Revenues generated by our NRE products group decreased by 17% in the third quarter of fiscal 2017 as compared to the prior year period, due to fewer projects for customers in the infrared, medical device and industrial markets. NRE revenue is project based and timing of any such projects is wholly dependent on our customers and their project activity. Accordingly, management does not include NRE in its projections or forecasts for purposes of developing its operating plan and budget.

Nine months ended March 31, 2017

Our revenue increased by 54% in the first nine months of fiscal 2017, as compared to the prior year period with growth driven predominantly from the HVPMO and infrared product groups. We have seen strong growth in our core business from the telecommunications sector, and our infrared business has expanded significantly with the Acquisition of ISP.

Our unit shipment volume in LVPMO lenses increased by 26% in the first nine months of fiscal 2017, as compared to the same period of the prior fiscal year, which resulted in a 17% increase in revenue in the third quarter of fiscal 2017, compared to the same period of the prior fiscal year. This increase is attributed to growth in sales to customers in the defense, telecommunications and industrial sectors. The average selling price decreased by 7%, compared to the same period in the prior year due to market conditions.

The HVPMO product group benefitted from the strength in the telecommunications sector as the demand for increased bandwidth continues. During the first nine months of fiscal 2017, sales of HVPMO lens units increased by 48%, and the average selling price increased by 49%, both as compared to the prior period, which produced a 121% increase in HVPMO revenue as compared to the prior year period. The increases are due to the continued strength of the telecommunications sector, as well as some recovery of the Chinese industrial tool market. Historically, revenue from our HVPMO product group had been derived from the industrial tool market in China, which had experienced six years of declining growth.

We had significant growth in the infrared product group, which includes revenues generated by ISP. During the first nine months of fiscal 2017, sales of infrared units increased by 226%, as compared to the prior year periods, resulting in infrared product revenue increasing by 375% in the first nine months of fiscal 2017 as compared to the prior year period. The increases in revenue and units sold primarily derived from sales to customers in the thermal market.

In the first nine months of fiscal 2017, our specialty product revenue decreased by 40%, as compared to the prior year period. The decrease in revenue is due to revenues generated in the prior period from the sales of our fiber collimator assemblies sold to a customer pursuant to a license agreement, which did not continue in the current period. Approximately $1.0 million of the specialty group sales from the first nine months of fiscal 2016 was due to a final order of custom fiber collimator assemblies. This specific product technology was transferred to the customer pursuant to a license agreement entered into in fiscal 2015. Thus, the customer is no longer placing orders for fiber collimator assemblies with us.

Revenues generated by our NRE products group decreased by 32% in the first nine months of fiscal 2017 as compared to the prior year period, due to fewer projects for customers in the infrared, medical device and industrial markets. NRE revenue is project based and timing of any such projects is wholly dependent on our customers and their project activity. Accordingly, management does not include NRE in its projections or forecasts for purposes of developing its operating plan and budget.

| 34 |

Inventory Levels:

We manage our inventory levels to minimize investment in working capital but still have the flexibility to meet customer demand to a reasonable degree. Management constantly reviews our inventory amounts, and, if such amount substantially increases or decreases, management will further investigate the causes of any such fluctuations. While the amount and mix of inventory is an important factor, including adequate safety stocks of long lead-time materials, another important aggregate measure of inventory in all phases of production is the quarter’s ending inventory expressed as a number of days’ worth of the quarter’s cost of sales, also known as “days cost of sales in inventory,” or “DCSI.” It is calculated by dividing the quarter’s ending inventory by the quarter’s cost of goods sold, multiplied by 365 and divided by 4. Generally, a lower DCSI measure equates to a lesser investment in inventory and therefore more efficient use of capital. During the quarters ended March 31, 2017 and 2016, our DCSI was 109 and 178 respectively, compared to an average DCSI of 163 for the year ended June 30, 2016. The decrease in DCSI from the previous fiscal year end is due to the addition of ISP’s cost of goods and inventory.

Accounts Receivable Levels and Quality:

Similarly, we manage our accounts receivable to minimize investment in working capital. We measure the quality of receivables by the proportions of the total that are at various increments past due from our normally extended terms, which are generally 30 days. Management closely manages outstanding accounts receivables and promptly takes action once amounts are outstanding more than 30 days. An important aggregate measure of accounts receivable is the quarter’s ending balance of net accounts receivable expressed as a number of days’ worth of the quarter’s net revenues, also known as “days sales outstanding,” or “DSO.” It is calculated by dividing the quarter’s ending net accounts receivable by the quarter’s net revenues, multiplied by 365 and divided by 4. Generally, a lower DSO measure equates to a lesser investment in accounts receivable, and therefore, more efficient use of capital. For the quarters ended March 31, 2017 and 2016, our DSO was 62 and 67, respectively. For the year ended June 30, 2016, our average DSO was 65. The addition of ISP’s receivables and revenue has decreased DSO as compared to the previous prior year period. We strive to have a DSO no higher than 65.

Other Key Indicators:

Other key indicators include various operating metrics, some of which are qualitative and others are quantitative. These indicators change from time to time as the opportunities and challenges in the business change. They are mostly non-financial indicators such as on time delivery trends, units of shippable output by major product line, production yield rates by major product line, and the output and yield data from significant intermediary manufacturing processes that support the production of the finished shippable product. These indicators can be used to calculate such other related indicators as fully-yielded unit production per-shift, which varies by the particular product and our state of automation in production of that product at any given time. Higher unit production per shift means lower unit cost, and, therefore, improved margins or improved ability to compete where desirable for price sensitive customer applications. The data from these reports is used to determine tactical operating actions and changes. Management also assesses business performance and makes business decisions regarding our operations using certain non-GAAP measures. These non-GAAP measures are described in more detail below under the heading “Non-GAAP Financial Measures.”

Non-GAAP Financial Measures

We report our historical results in accordance with GAAP; however, our management also assesses business performance and makes business decisions regarding our operations using certain non-GAAP measures. We believe these non-GAAP financial measures provide useful information to management and investors that is supplementary to our financial condition and results of operations computed in accordance with GAAP; however, we acknowledge that our non-GAAP financial measures have a number of limitations. As such, you should not view these disclosures as a substitute for results determined in accordance with GAAP, and they are not necessarily comparable to non-GAAP measures that other companies use.

| 35 |

Adjusted Net Income:

We calculate adjusted net income by excluding the change in the fair value of the June 2012 Warrants from net income. The fair value of the June 2012 Warrants is re-measured each reporting period until the warrants are exercised or expire. Each reporting period, the change in the fair value of the June 2012 Warrants is either recognized as non-cash expense or non-cash income. The change in the fair value of the June 2012 Warrants is not impacted by our actual operations but is instead strongly tied to the change in the market value of our Class A common stock. Management uses adjusted net income to evaluate our operating performance and for planning and forecasting future business operations. We believe the use of adjusted net income may be useful to investors as one means of evaluating our operational performance. The following table reconciles adjusted net income to net income for the three and nine months ended March 31, 2017 and 2016:

|  | (Unaudited) |  |  | (Unaudited) |
|  | Three months ended: |  |  | Nine months ended: |
|  | Mar. 31, 2017 |  |  | Mar. 31, 2016 |  |  | Mar. 31, 2017 |  |  | Mar. 31, 2016 |
Net income |  | $ | 100,824 |  |  | $ | 775,758 |  |  | $ | 1,338,987 |  |  | $ | 1,083,148 |
Change in fair value of warrant liability |  |  | 748,169 |  |  |  | (661,854 | ) |  |  | 457,784 |  |  |  | 25,211 |
Adjusted net income |  | $ | 848,993 |  |  | $ | 113,904 |  |  | $ | 1,796,771 |  |  | $ | 1,108,359 |
% of revenue |  |  | 10 | % |  |  | 3 | % |  |  | 9 | % |  |  | 9 | %

Our adjusted net income for the three months ended March 31, 2017 was approximately $849,000, as compared to adjusted net income of approximately $114,000 for the three months ended March 31, 2016. The difference in adjusted net income between the periods was principally caused by higher revenue generating higher gross margins. The third quarter of fiscal 2017 was also favorably impacted by the Acquisition of ISP.

Our adjusted net income for the nine months ended March 31, 2017 was approximately $1.8 million, as compared to adjusted net income of approximately $1.1 million for the nine months ended March 31, 2016. The difference in adjusted net income between the periods was principally caused by higher revenues generating higher gross margins, which was partially due to the Acquisition of ISP.

EBITDA and Adjusted EBITDA:

EBITDA and adjusted EBITDA are non-GAAP financial measures used by management, lenders, and certain investors as a supplemental measure in the evaluation of some aspects of a corporation’s financial position and core operating performance. Investors sometimes use EBITDA as it allows for some level of comparability of profitability trends between those businesses differing as to capital structure and capital intensity by removing the impacts of depreciation and amortization. EBITDA also does not include changes in major working capital items such as receivables, inventory and payables, which can also indicate a significant need for, or source of, cash. Since decisions regarding capital investment and financing and changes in working capital components can have a significant impact on cash flow, EBITDA is not a good indicator of a business’s cash flows. We use EBITDA for evaluating the relative underlying performance of our core operations and for planning purposes. We calculate EBITDA by adjusting net income to exclude net interest expense, income tax expense or benefit, depreciation and amortization, thus the term “Earnings Before Interest, Taxes, Depreciation and Amortization” and the acronym “EBITDA.”

We also calculate an adjusted EBITDA, which excludes the effect of the non-cash income or expense associated with the mark-to-market adjustments, related to our June 2012 Warrants. The fair value of the June 2012 Warrants is re-measured each reporting period until the warrants are exercised or expire. Each reporting period, the change in the fair value of the June 2012 Warrants is either recognized as a non-cash expense or non-cash income. The change in the fair value of the June 2012 Warrants is not impacted by our actual operations but is instead strongly tied to the change in the market value of our Class A common stock. Management uses adjusted EBITDA to evaluate our underlying operating performance and for planning and forecasting future business operations. We believe this adjusted EBITDA is helpful for investors to better understand our underlying business operations. The following table reconciles EBITDA and adjusted EBITDA to net income for the three and nine months ended March 31, 2017 and 2016:

|  | (Unaudited) |  |  | (Unaudited) |
|  | Three months ended: |  |  | Nine months ended: |
|  | Mar. 31, 2017 |  |  | Mar. 31, 2016 |  |  | Mar. 31, 2017 |  |  | Mar. 31, 2016 |
Net income |  | $ | 100,824 |  |  | $ | 775,758 |  |  | $ | 1,338,987 |  |  | $ | 1,083,148 |
Depreciation and amortization |  |  | 721,636 |  |  |  | 219,377 |  |  |  | 1,240,232 |  |  |  | 609,029 |
Income taxes |  |  | 265,774 |  |  |  | 126,970 |  |  |  | 771,600 |  |  |  | 131,054 |
Interest expense |  |  | 192,977 |  |  |  | 8,287 |  |  |  | 206,170 |  |  |  | 30,100 |
EBITDA |  | $ | 1,281,211 |  |  | $ | 1,130,392 |  |  | $ | 3,556,989 |  |  | $ | 1,853,331 |
Change in fair value of warrant liability |  |  | 748,169 |  |  |  | (661,854 | ) |  |  | 457,784 |  |  |  | 25,211 |
Adjusted EBITDA |  | $ | 2,029,380 |  |  | $ | 468,538 |  |  | $ | 4,014,773 |  |  | $ | 1,878,542 |
% of revenue |  |  | 24 | % |  |  | 11 | % |  |  | 21 | % |  |  | 15 | %

36

Our adjusted EBITDA for the three months ended March 31, 2017 was approximately $2.0 million, compared to approximately $469,000 for the three months ended March 31, 2016. The difference in adjusted EBITDA between the periods was principally caused by higher operating income recognized in the three months ended March 31, 2017 due to higher revenues.

Our adjusted EBITDA for the nine months ended March 31, 2017 was approximately $4.0 million, compared to approximately $1.9 million for the nine months ended March 31, 2016. The difference in adjusted EBITDA between the periods was principally driven by higher operating income recognized in the nine months ended March 31, 2017 due to higher revenues.

Off Balance Sheet Arrangements

We do not engage in any activities involving variable interest entities or off-balance sheet arrangements.

Critical Accounting Policies and Estimates

Allowance for accounts receivable is calculated by taking 100% of the total of invoices that are over 90 days past due from due date and 10% of the total of invoices that are over 60 days past due from the due date for U.S. based accounts and 100% on invoices that are over 120 days past due for China and Latvia based accounts without an agreed upon payment plan. Accounts receivable are customer obligations due under normal trade terms. We perform continuing credit evaluations of our customers’ financial condition. Recovery of bad debt amounts which were previously written-off is recorded as a reduction of bad debt expense in the period the payment is collected. If our actual collection experience changes, revisions to our allowance may be required. After attempts to collect a receivable have failed, the receivable is written off against the allowance.

Inventory obsolescence reserve is calculated by reserving 100% for items that have not been sold in two years or that have not been purchased in two years or which we have more than a two year supply. These items as identified are reserved at 100%, as well as reserving 50% for other items deemed to be slow moving within the last twelve months and reserving 25% for items deemed to have low material usage within the last six months. The parts identified are adjusted for recent order and quote activity to determine the final inventory reserve.

Revenue is recognized from product sales when products are shipped to the customer, provided that we have received a valid purchase order, the price is fixed, title has transferred, collection of the associated receivable is reasonably assured, and there are no remaining significant obligations. Revenues from product development agreements are recognized as milestones as completed in accordance with the terms of the agreements and upon shipment of products, reports or designs to the customer. Invoiced amounts for value-added taxes (VAT) related to sales are posted to the balance sheet and not included in revenue. Revenue recognized from equipment leasing is recognized over the lease term.

Stock based compensation is measured at grant date, based on the fair value of the award, and is recognized as an expense over the employee’s requisite service period. We estimate the fair value of each stock option as of the date of grant using the Black-Scholes-Merton pricing model. Most options granted under the Plan vest ratably over two to four years and generally have ten-year contract lives. The volatility rate is based on four-year historical trends in common stock closing prices and the expected term was determined based primarily on historical experience of previously outstanding options. The interest rate used is the U.S. Treasury interest rate for constant maturities. The likelihood of meeting targets for option grants that are performance based are evaluated each quarter. If it is determined that meeting the targets is probable then the compensation expense will be amortized over the remaining vesting period.

Item 4. Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of March 31, 2017, the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2017 in reporting on a timely basis information required to be disclosed by us in the reports we file or submit under the Exchange Act.

37

During the fiscal quarter ended March 31, 2017, there was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II OTHER INFORMATION

Item 1. Legal Proceedings

None

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None

Item 3. Defaults Upon Senior Securities

None

Item 4. Mine Safety Disclosures

None

Item 5. Other Information

On April 27, 2017, our Board of Directors set October 26, 2017 as the date of our 2018 Annual Stockholders’ Meeting (the “Annual Meeting”). The Annual Meeting will be held at 11 a.m. (ET) at the Hyatt Regency Orlando International Airport Hotel located at 9300 Airport Boulevard, Orlando, Florida 32827.

The date of the Annual Meeting represents a change of more than 30 days from the anniversary of our 2017 Annual Stockholders’ Meeting, which was held on January 26, 2017. As a result, pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended, we have set a new deadline for the submission of stockholder proposals submitted pursuant to Rule 14a-8 for inclusion in our proxy statement for the Annual Meeting. The new deadline for the submission of such stockholder proposals is the close of business on May 19, 2017, which we believe is a reasonable time for the review, consideration, and if appropriate, inclusion of any such proposals before we begin to print and send our proxy materials to stockholders for the Annual Meeting.

In accordance with our Amended and Restated Bylaws (the “Bylaws”), stockholders who wish to present a proposal at the Annual Meeting, or nominate a director for election at the Annual Meeting, must provide written notice on or before May 15, 2017.

Any such proposal or notice should be delivered to: Corporate Secretary, at LightPath Technologies, Inc., 2603 Challenger Tech Court, Suite 100, Orlando Florida USA 32826 and must also comply with the procedures (including all information specified) in our Bylaws and the rules and regulations of the Securities and Exchange Commission under Rule 14a-8.

38

Item 6. Exhibits

The following exhibits are filed herewith as a part of this report.

Exhibit Number |  | Description |  | Notes
3.1.1 |  | Certificate of Incorporation of Registrant, filed June 15, 1992 with the Secretary of State of Delaware |  | 1
3.1.2 |  | Certificate of Amendment to Certificate of Incorporation of Registrant, filed October 2, 1995 with the Secretary of State of Delaware |  | 1
3.1.3 |  | Certificate of Designations of Class A common stock and Class E-1 common stock, Class E-2 common stock, and Class E-3 common stock of Registrant, filed November 9, 1995 with the Secretary of State of Delaware |  | 1
3.1.4 |  | Certificate of Designation of Series A Preferred Stock of Registrant, filed July 9, 1997 with the Secretary of State of Delaware |  | 2
3.1.5 |  | Certificate of Designation of Series B Stock of Registrant, filed October 2, 1997 with the Secretary of State of Delaware |  | 3
3.1.6 |  | Certificate of Amendment of Certificate of Incorporation of Registrant, filed November 12, 1997 with the Secretary of State of Delaware |  | 3
3.1.7 |  | Certificate of Designation of Series C Preferred Stock of Registrant, filed February 6, 1998 with the Secretary of State of Delaware |  | 4
3.1.8 |  | Certificate of Designation, Preferences and Rights of Series D Participating Preferred Stock of Registrant filed April 29, 1998 with the Secretary of State of Delaware |  | 5

3.1.9 |  | Certificate of Designation of Series F Preferred Stock of Registrant, filed November 2, 1999 with the Secretary of State of Delaware |  | 6
3.1.10 |  | Certificate of Amendment of Certificate of Incorporation of Registrant, filed February 28, 2003 with the Secretary of State of Delaware |  | 7
3.1.11 |  | Certificate of Amendment of Certificate of Incorporation of LightPath Technologies, Inc., filed March 1, 2016 with the Secretary of State of Delaware |  | 9
3.2 |  | Amended and Restated Bylaws of Registrant |  | 1
31.1 |  | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 |  | *
31.2 |  | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 |  | *
32.1 |  | Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350 of Chapter 63 of Title 18 of the United States Code |  | *
32.2 |  | Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350 of Chapter 63 of Title 18 of the United States Code |  | *

101.INS | XBRL Instance Document | *
101.SCH | XBRL Taxonomy Extension Schema Document | *
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | *
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | *
101.LAB | XBRL Taxonomy Extension Label Linkbase Document | *
101.PRE | XBRL Taxonomy Presentation Linkbase Document | *

Notes:

1. This exhibit was filed as an exhibit to our Current Report on Form 8-K (File No: 000-27548) filed with the Securities and Exchange Commission on February 3, 2015 and is incorporated herein by reference thereto.

2. This exhibit was filed as an exhibit to our annual report on Form 10-KSB40 (File No: 000-27548) filed with the Securities and Exchange Commission on September 11, 1997 and is incorporated herein by reference thereto.

3. This exhibit was filed as an exhibit to our quarterly report on Form 10-QSB (File No: 000-27548) filed with the Securities and Exchange Commission on November 14, 1997 and is incorporated herein by reference thereto.

39

4. This exhibit was filed as an exhibit to our Registration Statement on Form S-3 (File No. 333-47905) filed with the Securities and Exchange Commission on March 13, 1998 and is incorporated herein by reference thereto.

5. This exhibit was filed as an exhibit to our Registration Statement on Form 8-A (File No: 000-27548) filed with the Securities and Exchange Commission on April 28, 1998 and is incorporated herein by reference thereto.

6. This exhibit was filed as an exhibit to our Registration Statement on Form S-3 (File No: 333-94303) filed with the Securities and Exchange Commission on January 10, 2000 and is incorporated herein by reference thereto.

7. This exhibit was filed as an exhibit to our Proxy Statement (File No: 000-27548) filed with the Securities and Exchange Commission on January 24, 2003 and is incorporated herein by reference thereto.

8. This exhibit was filed as an exhibit to our Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 14, 2016.

9. This exhibit was filed as an exhibit to our Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on February 14, 2017 and is incorporated herein by reference thereto.

* filed herewith

40

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

| LIGHTPATH TECHNOLOGIES, INC.
Date: May 4, 2017 | By: | /s/ J. James Gaynor
| President and Chief Executive Officer
Date: May 4, 2017 | By: | /s/ Dorothy M. Cipolla
| Chief Financial Officer

41